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Candida albicans ist ein normalerweise harmloser, kommensaler Pilz und Teil des humanen Mi-
krobioms, wo er auf der Haut und den Schleimhäuten des Darms und der Mundhöhle gefunden
werden kann. In immungeschwächten Patienten kann C. albicans jedoch Krankheiten mit unter-
schiedlichen Schweregraden auslösen. Diese erstrecken sich von oberächlichen Infektionen des
Oropharynx oder der Vagina zu lebensbedrohlichen systemischen Blutstrominfektionen. Welt-
weit gehört C. albicans zu den häugsten Erregern von nosokomialen Pilzinfektionen. Eine sei-
ner wichtigsten Virulenzfaktoren ist die Fähigkeit, in Abhängigkeit von der umgebenden Nische,
reversibel von Hefen- zu Hyphenwachstum überzugehen. Die Hochregulierung sogenannter hy-
phenspezischer Gene ist eng mit diesem morphologischen Übergang verbunden. Dieser Gruppe
gehören einige virulenzassoziierte Gene, wie ALS3 und ECE1, an. Das letztere ist eines der
am höchsten exprimierten Gene in Hyphen und kodiert ein Vorgängerprotein des Peptidtoxins
Candidalysin. Während der Invasion der Wirtzellen durch den Pilz wird Candidalysin von den
Hyphen in Invasionstaschen sekretiert, wo es die Zytolyse von Wirtszellen vermittelt. Aufgrund
der Bedeutung für die Virulenz des Pilzes hat die Erforschung der Regulation von ECE1 einen
groÿen Wert und trägt zum Verständnis der Pathogenitätsmechanismen von C. albicans bei.
Während der Untersuchung von Deletionsmutanten von Transkriptionsfaktoren wurde festge-
stellt, dass Ahr1 wichtig für die hohe Expression von ECE1 ist. Eine Mutante, der dieser Tran-
skriptionsregulator fehlt, zeigte eine mittelgradige ECE1 Transkription, niedrige Candidalysin-
sekretion und eine abgeschwächte Virulenz in einem oralen Epithelzellmodel. Im Gegensatz dazu
induzierte ein hyperaktives Ahr1 eine hohe Expression von ECE1 sogar unter Hefenbedingun-
gen und umging die Abwesenheit zahlreicher Trankriptionsfaktoren einschlieÿlich Brg1, Efg1 und
Ume6. Ein ähnliches Regulationsmuster konnte für das hyphenspezische ALS3 Gen beobachtet
werden, welches für ein wichtiges Adhesin und Invasin kodiert. Chromatinimmunoprezipitation
DNA Sequenzierung bewies, dass ein hyperaktives Ahr1 stromaufwärt von ECE1, ALS3 und an-
deren hyphenspezischen Genen bindet. Es wurde auch an den Promotoren von zahlreichen Regu-
latorgenen, inklusive BRG1 und UME6 gefunden. Diese Bindung ging mit der Hochregulierung
dieser Transkriptionsfaktorgene einher. MCM1 kodiert einen essentiellen Transkriptionsfaktor
und Bindepartner von Ahr1. In einem teils Ahr1-abhängigem Prozess sorgte die Überexpression
von MCM1 für die Hochregulierung der ECE1 und ALS3 Expression. Interessanterweise zeigt
diese Studie, dass Tup1, normalerweise ein globaler Repressor der Hyphenentwicklung und der
assoziierten Genexpression, benötigt wird für den nützlichen Eekt des hyperaktiven AHR1 Al-
lels und der MCM1 Überexpression. Dies deutet darauf hin, dass Tup1 nicht nur als Repressor
arbeitet sondern auch für die hohe Expression von ECE1 und ALS3, welche über Ahr1 und
Mcm1 vermittelt wird, erforderlich ist. Zusätzlich wurde entdeckt, dass eine Punkmutation eines
Allels des SSN3 Gens, welches eine cyclin-abhängige Kinase kodiert, die Expression dieser beiden
Gene unabhängig von Ahr1, Tup1, Efg1 und Cph1 aktivieren kann. Zusammenfassend betrachtet
identizierte diese Studie neue Mitwirkende im komplexen Regulatornetzwerk, welches die Tran-
skription von virulenzassoziierten Genen in den unterschiedlichen Morphologien von C. albicans




Candida albicans is a normally harmless commensal fungus and part of the human microbiota
where it can be found on the skin and mucosal surfaces of the gut and the oral cavity. However,
in immunocompromised patients, C. albicans can cause diseases of dierent severity. These can
range from supercial infections of the oropharynx or the vagina to life threatening systemic
bloodstream infections. C. albicans is one of the most common causes for nosocomial fungal
infections worldwide. A major virulence trait is its ability to undergo reversible yeast-to-hyphae
transition depending on the environmental niche. The up regulation of so called hyphae-specic
genes is tightly linked to this morphological transition. This group of genes includes several
virulence-associated ones, like ALS3 and ECE1. The latter is one of the most highly expressed
genes in hpyhae and encodes for a precursor protein of the peptide toxin Candidalysin. During
fungal invasion of host cells, Candidalysin is secreted into invasion pockets by the hyphae where
it mediates host cell cytolysis. Due to its importance for the virulence of the fungus, research on
the regulation of ECE1 is of great value and contributes to the understanding the pathogenicity
mechanisms of C. albicans.
During a screen of transcription factor deletion mutants, Ahr1 was identied to be important for
the high-level expression of ECE1 in C. albicans hyphae. A mutant lacking this transcriptional
regulator is characterized by intermediate ECE1 transcription, low secretion of Candidalysin and
attenuated virulence in an oral epithelial cell infection model. In contrast, a hyperactive AHR1
allele induces high levels of ECE1 expression even under yeast growth conditions. Furthermore, it
can bypass the absence of several transcription factors, including Brg1, Efg1 and Ume6. A similar
regulatory pattern could be observed for the hypha-specic ALS3 gene, which encodes for an
important adhesin and invasin. Chromatin immunoprecipitation DNA sequencing proved that a
hyperactive Ahr1 binds upstream of ECE1, ALS3, and other hyphae-associated genes. It was also
found on the promoters of several regulatory genes including BRG1 and UME6 and this binding
correlated with an upregulation of these transcription factor genes. In a partially Ahr1-dependent
process, overexpression of MCM1, which encodes an essential transcription factor and binding
partner of Ahr1, led to the upregulation of ECE1 and ALS3. Interestingly, it was found in this
study that Tup1, which is normally a global repressor of hyphal development and associated gene
expression, is required for the benecal eects of the hyperactive AHR1 allele as well as ofMCM1
overexpression. This indicates that Tup1 does not only work as a repressor but is also required for
high-level expression of ECE1 and ALS3 mediated by Ahr1 and Mcm1. In addition, it was also
found that a point-mutated allele of the SSN3 gene, which encodes a cyclin-dependent kinase,
could activate expression of the two genes without involvement of Ahr1, Tup1, Efg1 and Cph1.
Overall, this study identies novel contributors to the complex regulatory network which controls
the transcription of virulence-associated genes in the dierent morphologies of C. albicans and





1.1. Candida species as causative agents of fungal infections
Species from the genus Candida are the world's second most common cause for invasive fungal
infections (Brown et al., 2012). According to estimates, 400,000 of these infections are inicted
by Candida species (spp.) each year with a mortality rate of 46-75% (Brown et al., 2012). This is
only exceeded by Cryptococcus spp., which account for approx. 1,000,000 infections worldwide.
In Germany Candida spp. are the most prevalent cause of invasive and non-invasive fungal infec-
tions (Ruhnke et al., 2015). In a nationwide surveillance study in the United States of America
(USA), it was found that Candida spp. were the most commonly isolated fungi from nosoco-
mial bloodstream infections (Wisplingho et al., 2004). While coagulase-negative staphylococci,
Staphylococcus spp. and Enterococcus spp. amounted to roughly 60% of bloodstream infections,
Candida spp. were responsible for 9% of the cases (Wisplingho et al., 2004). Similar numbers
were reported from German intensive care units, where 6.5% of primary nosocomial laboratory-
conrmed bloodstream infections were caused by Candida spp. (Meyer et al., 2013).
There are approximately 200 Candida spp. but only few of them are known colonizers of the
human body. Furthermore, only 16 species have already been isolated from infected patients
(Pfaller and Diekema, 2007; Polke et al., 2015; Yapar, 2014). From these, C. albicans, C. glabra-
ta, C. parapsilosis, C. tropicalis and C. krusei were identied as pathogens in more than 90% of
cases (Pfaller and Diekema, 2010, 2007; Yapar, 2014). Additionally, the new species C. auris has
been described for the rst time in 2009 (Satoh et al., 2009). In contrast to the other pathogenic
Candida spp., C. auris is able to readily spread in health-care facilities from human to human
and through other surfaces, causing nosocomial outbreaks. A review from Rhodes and Fisher
(2019) summarizes the current knowledge on C. auris.
As already mentioned, several Candida spp. are able to colonize healthy individuals. They usual-
ly reside as benign members of human microbiota on the mucosa and skin without causing any
disease symptoms. However, under certain conditions they are also able to cause infections in
their hosts. Three groups of people are especially vulnerable to infections by Candida spp., called
candidiasis. First of all, immunocompromised individuals for example, people in the extremes
of age, organ transplant recipients receiving immunosuppressive therapy, patients with the aqui-
red immunodeciency syndrome (AIDS) or cancer patients receiving chemotherapy can develop
candidiasis (Pfaller and Diekema, 2007; Arendrup, 2010; Viscoli et al., 1999). Second of all, in-
dividuals with a disequilibrium of the host microbiome (e. g. through the use of antibiotics)
are prone to opportunistic Candida infections (Pfaller and Diekema, 2007; Vincent et al., 2009;
Perlroth et al., 2007). Thirdly, patients where disruption of mucosal and cutanious barriers took
place (e. g. through burn wounds, surgery or central venous catheters) can develop candidiasis
(Moore et al., 2010; Lortholary et al., 2014; Ahlquist Cleveland et al., 2015). In these cohorts,
colonizing Candida can potentially proliferate on mucosal surfaces, invade tissues and possibly
further disseminate via the bloodstream from where they can reach and infect other organs.
Candida infections range from supercial infections of the mucosa, such as vulvovaginal or oro-
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pharyngeal candidiasis, to life-threatening systemic infections, like disseminated candidiasis and
candidemia (infection of the bloodstream with Candida). Oral or esophageal candidiasis, also cal-
led thrush, is especially common in AIDS (Fidel, 2011) and cancer patients (Lalla et al., 2010).
Oral candidiasis is also associated with the use of dentures (Salerno et al., 2011). At least 75% of
all women will have one or more episodes of vulvovaginal candidiasis (VVC) in their life (Sobel,
1997). Five to eight percent of them are suering from idiopathic recurrent infections (Sobel,
1997).
In immunocompromised people Candida species are able to reach the bloodstream through mu-
cosal surfaces (e. g. in the colon) or via central venous catheters. In a population based study in
the USA, 85% of 3,848 candidemia patients had a central venous catheter (Ahlquist Cleveland
et al., 2015). From the bloodstream the fungus can spread through the whole body, infecting
virtually all organs leading to invasive candidiasis and even sepsis.
Over the recent decades, an increase in candidemia was visible in dierent parts of the world
(Arendrup, 2010). A study, only focusing on patients in intensive care units in Germany, did not
come to the same conclusion (Meyer et al., 2013). Through advances in medical possibilities, more
aggressive surgery and transplantations, the use of broad spectrum antibiotics and an increased
survival of patients with severe illnesses, the amount of susceptible patients, especially in the
nosocomial setting, has increased (Arendrup, 2010; Perlroth et al., 2007). Due to this, it is not
surprising that risk factors for the development of invasive candidiasis include long-term stays
in intensive care units, central venous catheters and dierent kinds of abdominal surgery and
organ transplantation (Kullberg and Arendrup, 2016; Ahlquist Cleveland et al., 2015; Arendrup,
2010).
Additionally, several pathogenic Candida spp. have developed intrinsic resistances against the
common antimycotics used for the treatment of candidiasis (Arendrup, 2010). Only three known
classes of antimycotics are readily used for combating systemic Candida infections. First line
treatment of invasive candidiasis includes Echinocandins, which inhibit 1,3-β glucan synthase
and thus disrupt the cell wall composition (Denning, 2002). Azoles (e. g. Fluconazole, Itraco-
nazole, Voriconazole and Posaconazole) ght Candida infections by inhibiting lanosterol 14α-
demethylase in the ergosterol pathway, thus negatively inuencing membrane synthesis of the
fungus (Maertens, 2004). Amphotericin B is a polyene that binds to ergosterol in the fungal cell
wall, which results in pore formation and subsequent ion leakage and death (Lemke et al., 2005;
Gray et al., 2012).
1.2. The human fungal pathogen Candida albicans
C. albicans is a colonizer of mucosa of the gastrointestinal tract, the genitalia, the lower respi-
ratory tract, the oropharynx and the skin of 30-70% of healthy individuals (Polke et al., 2015;
Arendrup, 2010). It is the causative agent of 50-70% of invasive candidiasis (Arendrup, 2010;
Perlroth et al., 2007), which makes it the most clinically important Candida species. However,
over the last decades the incidence of C. albicans infections has slightly decreased, while other,
non-albicans species' prevalences have increased, e. g. C. glabrata and C. parapsilosis or C. tro-
picalis (Pfaller and Diekema, 2007; Yapar, 2014; Playford et al., 2010). Additionally, there are
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regional dierences in species distribution. While in North America, C. glabrata is the second
most common cause of invasive candidiasis, C. parapsilosis is the second most common cause in
Latin America (Yapar, 2014). Mice experiments from 2002 compared the virulence of the most
common pathogenic Candida spp. (Arendrup et al., 2002). C. albicans and C. tropicalis were
identied as the most virulent Candida species followed by C. glabrata, C. lusitaniae and C. ke-
fyr. In these experiments, C. parapsilosis, C. krusei and C. guilliermondii were the least virulent
of the species tested (Arendrup et al., 2002).
1.2.1. The polymorphism of C. albicans and virulence
During its long coevolution with the human host, C. albicans gained the ability to quickly adapt
to changing environments and stresses. This great repertoire of adaptation skills includes its
ability to readily switch between yeast, pseudohyphal and hyphal growth form depending on the
external conditions. C. albicans' unicellular budding yeast cells have a round to oval shape with
a diameter between 5-10 µm (Erwig and Gow, 2016). After budding, mother and daughter cell
readily separate from each other. True hyphae build long, tube-like, highly polarized laments
with parallele sides (Sudbery, 2011). Pseudohyphae are chains of elongated cells that adhere
to each other. They can be dierentiated from true hyphae, since they are wider and have
constrictions at septation sites (Sudbery, 2011). While true hyphae are said to be the invasive
form of the fungus, for a long time yeast cells were thought to be the commensal and noninvasive
form (Jacobsen et al., 2012; Berman and Sudbery, 2002). However, during invasive infections
not only hyphae but also yeast cells can be found (Odds, 1988). The ability to reversibly switch
between yeast and hyphal growth form is believed to be the major virulence trait of C. albicans.
During infection, yeast cells are deemed to support dissemination via the bloodstream (Berman
and Sudbery, 2002) whereas hyphae are reckoned to play a crucial role in tissue invasion (Saville
et al., 2003; Jacobsen et al., 2012). This idea is backed by studies which showed that yeast-
locked (Lo et al., 1997; Zheng et al., 2004) or hyphae-locked mutants (Braun et al., 2000) were
avirulent. A mutant lacking TUP1, a known repressor of hyphal growth, only grows as laments
and is avirulent in mouse models for systemic infections (Braun et al., 2000; Cleary et al., 2016).
It was already shown that the yeast-locked cph1∆/efg1∆ mutant is avirulent in a mouse tail
vein model and unable to escape from macrophages by forming hyphae (Lo et al., 1997), which
is a known mechanism of C. albicans to evade immune cells (Lorenz et al., 2004). However,
this mutant lacks two major transcription factors which are known activators of hyphal growth
and inuence not only morphology but also cell wall composition, adhesion and other virulence
associated traits of the fungus. Another research focusing on the virulence of non-lamentous
mutants was conducted by Zheng et al. (2004). They focused on the gene HGC1 which encodes
for a G1 cyclin-related protein and whose expression is induced in C. albicans hyphae. Deletion
of HGC1 led to a mutant unable to form hyphae under standard laboratory conditions and
within mice kidneys. In the hgc1∆ mutant, the expression of other hypha-specic genes, such
as HWP1, HYR1 and ECE1 was not impaired, making the hgc1∆ mutant a better candidate
to research the necessity of dimorphism for virulence than the cph1∆/efg1∆ mutant. Since the
hgc1∆ mutant showed reduced virulence compared to a revertant in a mouse tail vein model, it
supports the idea that morphological plasticity and virulence are connected in C. albicans.
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1.2.1.1. Regulation of hyphal development in C. albicans
Hyphal formation of C. albicans is induced by environmental conditions which resemble adverse
growth conditions in the human host. Among others, the presence of serum (Taschdjian et al.,
1960), elevated temperatures, neutral pH (Buo et al., 1984), 5% carbon dioxide (CO2, similar
to bloodstream conditions) (Mardon et al., 1969; Klengel et al., 2005; Bahn and Mühlschlegel,
2006), N-acetylglucosamine (GlcNAc) (Simonetti et al., 1974) and the growth in an embedded
matrix (Sudbery, 2011) stimulate hyphal growth. Additionally, synthetic growth medium such
as Lee's medium (Lee et al., 1975), Spider medium (Liu et al., 1994) or mammalian tissue cul-
ture media like M199 or RPMI 1640 can be used in the laboratory to induce hyphae formation
(Sudbery, 2011). One of the strongest inducers of hyphal formation is the combination of 37°C
and serum, which is therefore readily used in diagnostics to discriminate C. albicans from other
yeasts (Sudbery, 2011).
Three main signal transduction pathways have been described to induce yeast-to-hyphae tran-
sition: the mitogen-activated protein kinase (MAPK) signaling pathway, the cyclic adenosine
monophosphate-dependent protein kinase A (cAMP-PKA) pathway and the pH-dependent pa-
thway (Fig. 1).
Important transcription factors which positively inuence hyphal formation and the expression
of hypha-specic genes in these pathways are Efg1, Cph1, Flo8, and Rim101 (Ernst, 2000; Liu,
2001).
Through serum or low nitrogen availability, the transmembrane ammonium permease Mep2 acti-
vates both cAMP as well as MAPK signaling (Biswas and Morschhäuser, 2005). Ras1, a guanine
nucleotide binding protein, acts downstream of Mep2 and is an activator of both pathways though
changing from inactive GDP-bound to the active GTP-bound state (Leberer et al., 2001). Fur-
thermore, the cAMP pathway is induced indirectly via Ras1 physically interacting with Cyr1 or
directly via Cyr1 (Fang and Wang, 2006; Rocha et al., 2001). Cyr1 is the sole adenylyl cyclase in
C. albicans and thus the only source of cAMP in the fungus, which it synthesises from adenosine
triphosphate (ATP) (Rocha et al., 2001). CO2 and peptidoglycans in serum can directly stimu-
late Cyr1, which induces the cAMP production (Wang et al., 2010). Intracellular levels of cAMP
positively regulate yeast-to-hyphae transition (Harcus et al., 2004). The phosphodiesterases Pde1
and Pde2 convert cAMP to AMP which makes them negative regulators of lamentation (Jung
and Stateva, 2003). Intracellular cAMP activates the PKA complex. It consists of the two cata-
lytic subunits Tpk1 and Tpk2 and the regulatory subunit Bcy1, which functions as an essential
negative regulator of PKA complex (Bockmühl et al., 2001). The PKA complex directly phos-
phorylates the enhanced lamentous growth protein 1 (Efg1) at T206 (Bockmühl and Ernst,
2001). Efg1 is regarded as the master regulator of hyphae formation. Alternatively, Efg1 can
also be directly activated in the presence of GlcNAc by Ngt1 (Alvarez and Konopka, 2007). It
is a sequence-specic deoxyribonucleic acid (DNA) binding protein and binds to the E-box (5'-
CANNTG-3'), which is present in the promotors of several hypha-specic genes, such as ALS3,
ECE1, HWP1, HYE1 and RBT4 (Leng et al., 2001). It is activated via the cAMP pathway in
response to serum, elevated CO2 levels, neutral pH, GlcNAc and growth on solid media. Deletion
of EFG1 leads to lamentation defects under various conditions (Lo et al., 1997; Stoldt et al.,
1997; Braun and Johnson, 2000).
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Fig. 1: Schematic display of the regulation of hyphal development via MAPK, cAMP-
PKA and pH-dependent pathway in C. albicans.
Dierent environmental cues induce the MAPK (green), cAMP-PKA (pink) and pH-
dependent (purple) pathways via signal transduction factors (yellow). This leads to the
activation of the transcription factors Cph1, Flo8, Efg1 and Rim101 (blue) which induce
the transcription of hypha-specic genes and hyphae formation. Transcriptional repressors
(orange) prevent the expression of hypha-specic genes in yeast cells.
Modied from: Basso et al. (2019); Shapiro et al. (2011); Sudbery (2011); Liu (2001)
Another transcription factor which is supposed to act downstream of PKA is Flo8. It is requi-
red for lamentous growth under many conditions, interacts with Efg1 and controls a subset of
Efg1-regulates genes (Du et al., 2012; Cao et al., 2006).
Despite the already mentioned low levels of ammonium and serum, also temperatures of 37°C
and higher induce the MAPK pathway through blocking of Hsp90 (Shapiro et al., 2009). As
already mentioned, Ras1 also works upstream of the MAPK signaling cascade. Downstream of
Ras1 lies the Rho-type guanosine triphosphatase Cdc42 and its guanine exchange factor Cdc24
(Bassilana et al., 2003; Ushinsky et al., 2002). Together they activate the MAPK cascade in
which kinase Cst20 (p21-activated kinase (PAK)) phosphorylates Ste11 (MAPK kinase kinase
(MAPKKK)) (Alonso Monge et al., 2006). Ste11 in turn phosphorylates Hst7 (MAPK kinase
(MAPKK)), which phosphorylates Cek1 (MAPK) (Alonso Monge et al., 2006). Cek1 then acti-
vates the transcription factor Cph1, which induces the expression of hypha-specic genes (Liu
et al., 1994). Since Efg1 and Cph1 are the main transcription factors regulating the expression




C. albicans also forms hyphae under alkaline conditions. This is facilitated via the pH pathway,
which is dened by the transcription factor Rim101 and corresponding upstream activators. The
membrane proteins Rim21 and Dfg16 sense environmental pH (Barwell et al., 2005). In alkaline
condition, they activate Rim8 (Gomez-Raja and Davis, 2012). Subsequently, the C-terminal inhi-
bitory domain of Rim101 is cleaved o by the protease complex Rim13/Rim20 (Xu and Mitchell,
2001). This activates Rim101, which in turn positively regulates the expression of hypha-specic
genes (Bensen et al., 2004).
Under yeast growth conditions the expression of hypha-specic genes is inhibited. The general
corepressor Tup1 targets the promotors of hypha-specic genes via DNA-binding proteins such
as Nrg1 and the Rox1p-like regulator of lamentous growth (Rfg1), thereby negatively regulating
hyphal formation (Kadosh and Johnson, 2005). The deletion of any of these regulators (Tup1,
Nrg1 or Rfg1) induces the growth as long pseudohyphae and the derepression of hypha-specic
genes (Braun and Johnson, 1997; Kadosh and Johnson, 2005; Braun et al., 2001; Murad et al.,
2001a). Constitutive overexpression of NRG1 using a tet-promotor locked C. albicans in its yeast
state (Saville et al., 2006). Under these conditions the mutant remained in yeast state during
the infection of mice and was avirulent (Saville et al., 2006). Another transcription factor acting
downstream of PKA is the negative regulator of hyphal growth S1 (Bauer and Wendland, 2007).
Furthermore, several transcription factors have already been described to play a role in hyphal
formation and the expression of hypha-specic genes, which do not directly t into the pathway
system. Here, they will be described briey.
The expression of the transcription factor UME6 is induced upon dierent hypha-inducing con-
ditions and was shown to be important for hyphal extension in vitro and during infection in mice
(Banerjee et al., 2008). Furthermore, a ume6∆ mutant exhibited reduced virulence in a systemic
mouse model (Banerjee et al., 2008). Constitutive high-level and ectopic UME6 expression led
to the induction of several lament-specic genes (ECE1, HYR1, HWP1, HGC1, RBT1 ) and
a complete switch to hyphal morphology under non-inducing conditions (Zeidler et al., 2008;
Carlisle et al., 2009). Furthermore, the virulence of this mutant was increased in a mouse model
(Carlisle et al., 2009). However, inoculated cells were in yeast form and only in the mouse con-
stitutive UME6 expression was induced. This means yeast cells had some time to disperse in the
body before unanimously turning into hyhae (Carlisle et al., 2009).
Ndt80 was shown to regulate cell separation, germ tube formation, hyphal growth and virulence
(Yang et al., 2012; Sellam et al., 2010). Consequently, the ndt80∆ mutant was incapable of for-
ming biolms in a venous catheter model of infection (Nobile et al., 2012) and avirulent in mouse
models (Sellam et al., 2010; Yang et al., 2012). Furthermore, Ndt80 regulates the expression of
the multidrug transporter gene CDR1 and therefore has an inuence on drug resistance of C.
albicans (Chen et al., 2004). Deletion of NDT80 also negatively inuenced the expression of the
hypha-specic genes ALS3, ECE1, HWP1 and RBT4 (Sellam et al., 2010).
The forkhead transcription factor Fkh2 was shown to be needed for wild-type like expression
of core lamentation response (CFR, see Section 1.2.1.2) genes ECE1 and HWP1 after serum-
induction (Bensen et al., 2002). Knock-out of FKH2 lead to pseudohyphal formation under yeast
and hyphal growth conditions (Bensen et al., 2002). Additionally, the fkh2∆ mutant was unable
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to induce damage to human epithelial and endothelial cells in vitro (Bensen et al., 2002).
Askew et al. (2011) intensively studied the adhesion and hyphal regulator 1 (Ahr1). They iden-
tied the zinc-cluster transcription factor as a cofactor of Mcm1. Furthermore, they showed
that Ahr1 binds to promotors of genes encoding for adhesins (ALS2, ALS4, HWP1 ) and hyphal
regulators (EFG1 and TEC1 ) and recruits Mcm1 to these binding sites. Subsequently the Ahr1-
Mcm1-complex activated the expression of these genes. Lack of AHR1 resulted in signicantly
reduced adhesion on polystyrene, biolm density and attenuated virulence in a systemic mouse
model (Askew et al., 2011).
Tec1, a member of the TEA/ATTS family of transcription factors, is signicantly upregulated
during serum-induction at 37°C (Schweizer et al., 2003). Deletion of TEC1 disabled formation
of germ tubes and true hyphae through serum-induction and led to pseudohyphae formation in
vitro (Schweizer et al., 2003). Further on, Schweizer et al. (2003) showed that a tec1∆ mutant
was unable to evade monocytes, which the authors connected its inability to express secreted
aspatyl proteinases 4-6 (SAP4-6, for more information on Saps see Section 1.2.2.3). Mutants
lacking TEC1 were attenuated in a systemic mouse model but were able to form hyphae in vivo
(Schweizer et al., 2003).
Next to transcriptional regulators also other factors were already identied to have an inuence
on hyphal morphology. In a microevolution experiment the yeast-locked cph1∆/efg1∆ mutant
was passaged 42 times through macrophages until it regained its ability to lament and escape
macrophages (Wartenberg et al., 2014). Furthermore, CFR genes like ECE1, ALS3 and HWP1
as well as EED1, a gene encoding a regulator of hyphal extention (Zakikhany et al., 2007; Martin
et al., 2011), were again upregulated in the evolved cph1∆/efg1∆ mutant after serum-induction.
Wartenberg et al. (2014) identied a heterozygous, single nucleotide polymorphism (SNP) in
SSN3 as the causative mutation for these eects. Ssn3 is a cyclin-dependent kinase, which phos-
phorylates important regulators such as Ume6 (Lu et al., 2019).
1.2.1.2. Core lamentation response genes of C. albicans
As already mentioned, several dierent environmental cues can lead to hyphal formation and the
expression of hypha-specic genes of C. albicans. Transcriptome analyses and network modeling
showed that using three dierent of these well-dened stimuli (pH shift, addition of human serum
and N-acetylglucosamine) only eight genes were upregulated under all conditions (Martin et al.,
2013). This core lamention response (CFR) network comprises of the genes ALS3, DCK1, ECE1,
HGT2, IHD1, HWP1, RBT1 and orf19.2457. Most of the CFR genes encode proteins associated
with the cell wall or the cell membrane (Martin et al., 2013). Promotors of hypha-specic genes are
unusually long compared to other genes (Argimón et al., 2007). Argimón et al. (2007) calculated
that the 5' intergenic regions of seven hypha-specic genes (ALS3, ECE1, HGC1, HWP1, HYR1,
RBT1 and RBT4 ) have an average size of 4.5 kilo base pairs (bp), while estimated average lengths
of intergenic regions of divergently transcribed genes is 1,088 bp (Holton et al., 2001). This is,
with exception for DCK1, also true for the CFR genes (Martin et al., 2013). It has already been
speculated that the length of promotors of hypha-specic genes correlates to a highly complex
regulation of these genes. Corresponding to this, the intergentic regions of these genes usually




1.2.2. Filament-associated virulence factors of C. albicans
Polymorphism is an important virulence determinant of C. albicans. Additionally, the transition
from yeast to hyphal growth form is prerequisite for the expression of several genes encoding
for virulence factors. Furtheron, the polymorphism of C. albicans plays a crucial role in biolm
formation which supports virulence. The next sections will shine a light on very important
virulence factors that were already identied in the human fungal pathogen, several of them are
lament-associated.
1.2.2.1. Adhesion and biolm formation
Candida spp. are able to form biolms on medical devices such as catheters, dentures, joint
prosthetics and pacemakers (Kojic and Darouiche, 2004). Fungi residing in these biolms are
intrinsically resistant to antimycotics, which leads to considerable problems, especially in the
clinical setting (Kojic and Darouiche, 2004; Ahlquist Cleveland et al., 2015). Nobile and Johnson
(2015) describe the formation of biolms in four stages. First, yeast cells adhere to a surface. This
surface can be hard (e. g. medical device) or soft (e. g. mucosal layer). Secondly, cell proliferation
is initiated and a primal cell layer is built. Next, the biolm matures. This includes the formation
of hyphae and a simultanious construction of an extracellular matrix, which operates as a physical
barrier to drug seepage. The last step is the dispersal of yeast cells from the biolm. These yeast
cells can then conquer new sites in the human host. Depending on the case of Candida infections
and on whether or not the infection is device-related, a removal of the device additional to
concomitant antifungal therapy can be benecial for the recovery (Kojic and Darouiche, 2004).
The main adhesins studied in C. albicans belong to the agglutinin-like sequence (Als) family,
the hyphal cell wall protein (Hwp) family and the IPF family F/hyphally upregulated protein
(Hyr) family and possess a glycosylphosphatidylinositol (GPI) anchor (de Groot et al., 2013).
The transcription factor Bcr1 has been identied as a major regulator of adherence. It activates
the expression of adhesin and cell surface protein genes (such as ALS1, HWP1 and ALS3 ) and
thus regulates the ability of C. albicans to form biolms (Nobile and Mitchell, 2005; Nobile et al.,
2006). Bcr1 is dependent on Tec1 which plays an important role in hyphal formation (Nobile and
Mitchell, 2005). This shows that hyphal formation is connected to the expression of cell surface
genes which provide adhesive traits to the hyphae. This further supports robust formation of
biolms.
1.2.2.2. Agglutinin-like sequence 3 - Als3
Als3 is a member of the ALS gene family (for review see Hoyer et al. (2008)), a CFR gene (cf.
Sec. 1.2.1.2, Martin et al. (2013)) and an important virulence factor of C. albicans. The Als
family includes eight genes (ALS1-7 and ALS9 ) encoding for large cell-surface glycoproteins.
Each one consists of three domains. The N-terminal domain contains a substrate-binding region
which mediates binding to dierent materials. The central part is made of a number of 36-
amino acid tandem repeats which varies in size between dierent alleles and family members
(Oh et al., 2005; Hoyer et al., 2008). The third domain, the C-terminal domain, is rich in serine
and threonine. Additionally, it contains a GPI anchorage sequence, which suggests that all Als
proteins are cell wall associated (Hoyer et al., 2008). Due to the structure it was suggested that
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all Als proteins mediate binding to dierent substrates. This would confer the adaptation of C.
albicans to dierent host niches (Hoyer et al., 2008). However, only for some members of the Als
family adhesive functions were demonstrated (ALS1, ALS2, ALS3 ), while the contribution to
adhesion of others remains elusive (Hoyer et al., 2008). This study will focus on the CFR gene
Als3 (Martin et al., 2013), which was rst described as a hypha-specic gene in 1998 (Hoyer
et al., 1998).
Als3 was shown to be crucial for the adherence to endothelial cells, epithelial cells and the
reconstituted human epithelium but not to bronectin-coated plates (Phan et al., 2007; Zhao
et al., 2004). Furthermore, it is important for biolm formation. Nobile et al. (2006) showed that
the ability of the als3∆ mutant to form biolms after 2.5 h incubation in spider medium at
150 rpm and 37°C was dramatically reduced. Only a biolm of 20 µm depth, consisting of mainly
yeast and only few hyphal cells could be formed by the als3∆mutant. Under the same conditions,
a corresponding wild type was able to form a biolm of 200 µm depth, that comprised of mainly
hyphae (Nobile et al., 2006). This is especially interesting since deletion of ALS3 does not inhibit
hyphal formation under normally hypha-inducing conditions. Nevertheless, the mutant was still
able to form biolms in the rat venous catheters model after 24 h incubation (Nobile et al., 2006).
The same study also found that ALS3 expression is mediated by Bcr1 which is believed to act
downstream of Tec1.
Furthermore, Als3 is a important invasin. Phan et al. (2007) found that als3∆ hyphae were 90%
less endocytosed by endothelial and epithelial cells compared to wild type hyphae. Additionally,
they found that C. albicans needs Als3 to bind to dierent host cell surface proteins. They
identied N-cadherin on endothelial cells and E-cadherin on oral epithelial cells as targets of
Als3. Comparative structural analyses revealed that the N-terminus of Als3 strongly resembles
the N-termini of N- and E-cadherins. Due to this, the binding mechanism of Als3 to cadherins
is similar to that of cadherins binding to cadherins. This binding of Als3 to host cell cadherins
is necessary for the induction of endocytosis (Phan et al., 2007).
Additionally, Als3 is required for iron acquisition from host cell ferritin (Almeida et al., 2008).
Almeida et al. (2008) showed that while the als3∆ mutant only grew poorly on agar plates with
ferritin as sole carbon source, heterologous expression of ALS3 in S. cerevisiae allowed the yeast
to bind ferritin, which it normally is not able to do. The same study also found that deletion
of ALS3 resulted in a mutant unable to damage epithelial cells in vitro. This was also shown
with epithelial and endothelial cells in an earlier study (Phan et al., 2007). Additionally, it was
demonstrated that invading wild type hyphae were sourrounded by ferritin, which was not the
case for the als3∆ mutant (Almeida et al., 2008). Summing up, Als3 is an important adhesin
and invasin which is crucial for iron acquisition from host cell ferritin.
1.2.2.3. Secreted aspartyl proteinases - Saps
Other known virulence determinants of C. albicans are the secreted aspartyl proteinases, short
Saps. Other pathogenic Candida species have also been shown to produce Saps, such as C.
dubliniensis (Gilllan et al., 1998), C. tropicalis (Zaugg et al., 2001; Monod et al., 1994) and
C. parapsilosis (De Viragh et al., 1993; Monod et al., 1994). In C. albicans the Sap family is
encoded by 10 described SAP genes (reviewed by Naglik et al. (2003)). It is important to note
that Saps are dierentially expressed in the dierent morphologies of the fungus. In yeast cells
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SAP1-3 are upregulated (Hube et al., 1997). It was shown that deletion of one of these SAP
genes (SAP1, SAP2 and SAP3 ) led to attenuated virulence (Hube et al., 1997).
Hypha-associated Saps are encoded by SAP4, SAP5 and SAP6 and their expression is regulated
by Tec1 and Efg1 (Schweizer et al., 2003; Hube et al., 1994; Felk et al., 2002). These hydrolytic
enzymes were described to be important for the liberation of nutrients from host cells and to play
a role in the destruction and active penetration of tissue (Felk et al., 2002) and the evasion of
immune cells (Borg-von Zepelin et al., 1998). C. albicans hyphae require Sap4-6 for full virulence
and tissue penetration in vivo (Sanglard et al., 1997; Felk et al., 2002), but not for survival
after contact with neutrophils in blood (Fradin et al., 2005). Also, a correlation between Sap
production and adherence to host cells and subsequent virulence has already been described
(Abu-Elteen et al., 2001).
1.2.2.4. Superoxide dismutases - Sods
C. albicans and other pathogens encounter reactive oxygen species (ROS) in a variety of situa-
tions. During contact with the host immune system, the fungi can be confronted with ROS in
immune cells. Phagocytes produce superoxide radicals in the phagosome that can react with
cellular components and result in the disruption of cell membranes and ultimately death of the
pathogenic entity (Baldridge and Gerard, 1932; Bedard and Krause, 2007). This mechanism is
called oxidative burst. Apart from these external sources, the fungus can also be exposed to inter-
nal sources of superoxide radicals, for example in the mitochondrial respiratory chain (Boveris,
1978; Casteilla et al., 2002).
As protection mechanism, C. albicans, as well as other Candida spp., are able to express sever-
al superoxide dismutases (SODs), which neutralize superoxide anions. In C. albicans six Sods
have already been identied. SOD1 encodes a cytosolic copper- and zinc-containing superoxide
dismutase. Deletion of SOD1 leads to increased susceptibility to macrophages and a reduced vi-
rulence in a mouse model (Hwang et al., 2002). This suggests that Sod1 is important for coping
with external oxidative stress and thus has an inuence on the virulence of C. albicans (Hwang
et al., 2002). The gene SOD3 encodes for a cytoplasmic manganese-containing Sod, probably
involved in the protection against ROS during stationary phase of growth (Lamarre et al., 2001).
Sod5 has an GPI-anchor and is located on the cell surface, which suggests that it plays a role
in detoxifying external ROS (Fradin et al., 2005). Expression of SOD5 was shown to be induced
during hyphae formation (Martchenko et al., 2004; Fradin et al., 2005), osmotic and oxidative
stress (Martchenko et al., 2004) and in yeast cells when exposed to neutrophils (Fradin et al.,
2005). Sod5 plays a critical role for the survival of C. albicans in blood, especially in terms of
surviving contact with neutrophils (Fradin et al., 2005) but not with macrophages (Martchen-
ko et al., 2004). Deletion of SOD5 has a detrimental eect on the virulence in systemic mouse
models (Martchenko et al., 2004; Fradin et al., 2005). Summing up, C. albicans can express dif-
ferent superoxide dismutases which help the fungus to deal with oxidative stress from internal
and external sources. Furthermore, some Sods were shown to play an important protective role
for the fungus during infection and thus have an inuence on overall virulence.
1.2.2.5. Candidalysin
Candidalysin was discovered by Moyes et al. (2016) as the rst cytolytic peptide toxin in a human
10
1. Introduction
fungal pathogen. Since then, it was shown to be a major virulence factor of C. albicans. It is en-
coded by ECE1 (extent of cell elongation 1), a CFR gene (Martin et al., 2013) which belongs to
the most upregulated genes in C. albicans hyphae (Birse et al., 1993). However, ECE1 expression
is not necessary for hyphal formation (Birse et al., 1993). After translation, the 271 amino-acid
polypeptide Ece1 is being cleaved by Kex2 (golgi-located protease) after lysine-arginine (KR)
motifs (Bader et al., 2008; Moyes et al., 2016). This results in a total of eight peptides (Ece1-I to
Ece1-VIII), which are secreted by C. albicans hyphae (Bader et al., 2008; Moyes et al., 2016). For
Ece1-III (Candidalysin, encoded by bases 62-93) a subsequent second cleavage of the terminal
R by Kex1 was proven (Moyes et al., 2016). The two consecutive processing steps by Kex2 and
Kex1 are required to yield mature Candidalysin from the precursor Ece1 protein and critical for
the virulence of C. albicans (Richardson et al., 2018a). From all Ece1 peptides secreted by C.
albicans, only Candidalysin induces phosphorylation of MAPK phosphatase 1 (MKP1), c-Fos,
cytokines and damage in oral epithelial cells (Moyes et al., 2016). Thereby, low Candidalysin
concentratrations from 1.5 to 70 µM resulted in c-Fos DNA binding, while higher concentrations
over 70 µM were necessary to induce cell damage (Moyes et al., 2016). Candidalysin has lytic
as well as immunostimmunlatory activities. Due to it's amphipathic nature with a hydrophic
N-terminus with an alpha-helical structure and a hydrophilic C-terminus, it is able to interca-
late into cell membranes (Moyes et al., 2016). Even though an ece1∆ mutant was able to form
normal hyphae, adhered to and invaded human epithelial cells in a wild type-like fashion, it was
not able to induce epithelial danger responses (Moyes et al., 2016). An ece1∆+ECE1∆184−279
mutant, reconstituted with an ECE1 gene which lacks the coding region for Candidalysin, re-
sulted in a mutant similar to the ece1∆ mutant. It formed invasive hyphae but did not trigger
epithelial immune activation, damage or mucosal activation in a murine oropharyngeal candi-
diasis and a zebrash swimbladder model for moucosal infections (Moyes et al., 2016). Moyes
et al. (2016) concluded with a model of mocusal infections of C. albicans, which goes as follows.
While hyphae are invading epithelial cells they are forming membrane-bound invasion pockets
into which they secrete Candidalysin. There, the peptide accumulates. During the early phase of
infection, low concentrations of Candidalysin induce epithelial immunity without lysing the cell.
While the infection progresses, the Candidalysin level increases and the peptide intercalates into
the membrane. This leads to pore formation, subsequent permeabilization of the membrane and
calcium inux. Thus, Candidalysin directly damages epithelial membranes and induces innate
recognition (Moyes et al., 2016).
Since the rst description of Candidalysin, various research has been conducted to shine a light
on this critical virulence factor (for a detailed review on Candidalysin see Naglik et al. (2019)).
Several ndings will be summarized here.
A screen of fungal genome assemblies found that not only C. albicans but also C. tropicalis
and C. dubliniensis secrete Candidalysin. Interestingly, the Candidalysins of C. tropicalis and C.
dubliniensis showed increased potency on TR146 epithelial cells compared to C. albicans' Candi-
dalysin (Richardson et al., 2019). This is interesting, since an earlier mentioned study found that
C. albicans was the most virulent of several pathogenic Candida spp. tested (Arendrup et al.,
2002). This emphasizes that next to Candidalysin secretion also the other, earlier mentioned as
well as so far undiscovered factors are important for the virulence of dierent Candida species.
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Richardson et al. 2018 investigated the role of Candidalysin in vulvovaginal candidiasis (VVC)
and found that Candidalysin is also required for vaginal immunopathogenesis in vivo. First, they
applied Candidalysin to A431 vaginal epithelial cells and noticed dose-dependent proinamma-
tory cytokine response, damage and activation of c-Fos and MAPK signaling. This reaction was
similar to the normal response after fungal infection (Richardson et al., 2018b). Further on, they
used a mouse model for VVC, where dierent C. albicans mutants were intravaginally applied
to mice. While ece1∆+ECE1 mutant showed wild type like neutrophil recruitment, damage
and proinammatory cytokine expression, this was signicantly decreased in the ece1∆ and the
ece1∆+ECE1∆184−279 mutants, which lacked the part coding for Candidalysin, despite all mu-
tants forming hyphae in vaginal mucosa and there being no dierences in colonization noted after
three or seven days of infection (Richardson et al., 2018b).
During oropharyngeal candidiasis Candidalysin drives IL-1α/β production, which in turn ac-
tivates innate IL-17+TCRαβ+ cells. This induces the expression of IL-17, a proinammatory
cytokine, which is necessary for innate and adaptive immunity against C. albicans (Verma et al.,
2017). This protective response was shown to work only, once C. albicans hyphae start to invade
tissue and release Candidalysin and not during commensal growth of the fungus (Verma et al.,
2017).
Once commensal C. albicans switch to a pathogenic state, they are recognized by the immune
system and taken up by macrophages. In the phagosome of the macrophages, the fungus forms
hyphae, putting mechanical force on the membranes and ultimately killing the host cell. The fun-
gus can then grow out and escape the immune cell (Vylkova and Lorenz, 2014; McKenzie et al.,
2010). During pyroptosis, inammasome-mediated proinammatory cytokine IL-1β is secreted
through pores in cellular membranes which leads to swelling, membrane rupture and ultimate-
vely cell death (Wellington et al., 2014; Uwamahoro et al., 2014). A combination of pyroptosis
and hyphal formation are known mechanisms by which macrophage cell death is achieved after
uptake of C. albicans cells. Kasper et al. (2018) took a closer look at the eect of Candidalysin on
macrophages and dendritic cells. They found that Candidalysin activates the NLRP3 inamma-
some via potassium inux, which leads to caspase-1-dependent maturation and IL-1β secretion
of human macrophages (Kasper et al., 2018). This suggests that there is a third mechanism of
C. albicans-mediated cell death of mononuclear phagocytes through Candidalysin, apart from
pyroptosis and hyphal formation (Kasper et al., 2018).
Swidergall et al. (2019) showed that Candidalysin is critical for MAPK signaling (induction of
c-Fos and phospho-c-Jun, phospho-MEK1/2 and phospho-ERK1/2) and lactate dehydrogenase
(LDH) release in endothelial cells. Furthermore, they revealed that Candidalysin is required for
neutrophil recruitment and virulence during systemic infections in mice and zebrash (Swidergall
et al., 2019).
Ho et al. (2019) demonstrated that Candidalysin indirectly induces the phosohorylation and thus
activation of the epithelial growth factor receptor in vitro and in vivo in a murine model of oro-
pharyngeal candidiasis. In case this receptor was inhibited, induction of c-Fos, phosphorylation
of MPK1 and various cytokines by C. albicans and Candidalysin was repressed (Ho et al., 2019).
Impairment of the epithelial growth factor receptor with inhibitors led to sh death in 70%
of the cases in a zebrash swimbladder model for mucosal C. albicans infections. Control sh
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treated with dimethyl sulfoxide completely survived the infection with C. albicans. Additionally,
the authors noted a signicant reduction in neutrophil recruitment to infection sites, when the
epithelial growth factor receptor was inhibited (Ho et al., 2019).
Recently, Candidalysin was shown to foster alcohol-related liver diseases (Chu et al., 2019).
1.3. Aim of this study
Candidalysin is necessary for the induction of host cell damage and therefore plays a critical part
in mucosal and systemic infections of Candida albicans. ECE1, the gene encoding Candidalysin,
is usually the most abundant transcript in hyphae but barely detectable in yeast cells. Defects
in hyphal morphology are usually accompanied by a reduced ECE1 expression. However, the
regulatory network which induces the expression of ECE1 in C. albicans hyphae is so far not
fully understood. In this work, the activation of ECE1 transcription in hyphae was investigated.
The specic aims of this works were:
 Identication of important transcriptional activators of ECE1 and possible interaction
partners in C. albicans hyphae
 Investigation of possible regulatory overlaps between ECE1 and other core lamentation
response genes such as ALS3
 Determine if known activators of hyphae-specic genes are required for the expression of
ECE1 and other core lamentation response genes
 Evaluation of activator binding on chromatin and identication of possible targets
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2. Material and Methods
2.1. Strains
Tab. 1: C. albicans strains used in this study




ahr1∆ ahr1∆::FRT ahr1∆::FRT B. Bötttcher 271 (1)
ahr1∆
+ pADH1-AHR1 -GAD
ADH1/adh1::AHR1-GAD-SAT1 This study 517 (271)
ahr1∆
+ pADH1-MCM1
ADH1/adh1::MCM1-SAT1 E. Garbe 352 (271)
ahr1∆
+ pADH1-SSN3m
















ADH1/adh1::MCM1-SAT1 This study 414 (128)
ahr1∆
pADH1-SSN3m































ADH1/adh1::AHR1-GAD-SAT1 R. Martin 157 (104)
cph1∆/efg1∆
+ pADH1-SSN3m





ADH1/adh1::MCM1-SAT1 This study 462 (104)
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Liu et al. (1994) 349 (CAI4)
cph1∆ + pECE1 -GFP ECE1/ece1::GFP-SAT1 E. Garbe 201 (349)
cph1∆/efg1∆
+ pADH1-SSN3m






Lo et al. (1997) 5 ( CAI4)
cph1∆/efg1∆
+ pECE1 -GFP
ECE1/ece1::GFP-SAT1 A. Haeder 78 (5)
efg1∆
efg1::hisG/efg1::hisG-URA3-hisG
Lo et al. (1997) 4 (CAI4)
efg1∆
+ pECE1 -GFP


















R. Martin 196 (SN87)
fkh2∆
+ pECE1 -GFP
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R. Martin 427 (1)
SC5314
+ pADH1-MCM1
ADH1/adh1::MCM1-SAT1 E. Garbe 350 (1)
SC5314
+ pADH1-SSN3m













ECE1/ece1::GFP-ARG4 This study 522 (251)
ssn3∆
+ pADH1-AHR1-GAD

















ECE1/ece1::GFP-ARG4 R. Martin 150 (145)





ADH1/adh1::AHR1-GAD-SAT1 This study 438 (14)
tup1∆
+ pADH1-MCM1
ADH1/adh1::MCM1-SAT1 This study 439 (14)
tup1∆
+ pADH1-SSN3m











tup1∆ +pECE1 -GFP ECE1/ece1::GFP-ARG4 R. Martin 132 (116)
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tup1∆ + pECE1 -GFP
+ pADH1-AHR1 -GAD
ADH1/adh1::AHR1-GAD-ARG4 This study 268 (132)
tup1∆ + pECE1 -GFP
+ pADH1-SSN3m









ECE1/ece1::GFP-SAT1 R. Martin 214 (12)
2.2. Plasmids


















regions for integration into
CaECE1 locus




AHR1 ORF without stop
codon, fused with GAL4
activator domain and HA3-tag,
CaSAT1 gene, homology
regions for integration into
CaADH1 locus





AHR1 ORF without stop
codon, fused with GAL4
activator domain and HA3-tag,
CaSAT1 gene, homology
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2.3. Primers
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* lower case letters indicate restriction sites, homology regions to the target gene are written in
italics




GFP veri rev TGATCTGGGTATCTCGCAAAGCAT
G4-AGO1-2 CTGGGCCAATTTCTGAGGCAGCA
CaACT1term veri rev GAATACAAAACCAGATTTCCAGATTTCCAG





2.4. Strain maintenance and growth conditions
Routinely, C. albicans strains were taken from cryo stocks and incubated for one to three days
on yeast extract peptone dextrose agar plates (YPD, 20 g/l peptone, 10 g/l yeast extract, 20 g/l
glucose, 20 g/l agar-agar, pH 5) at 30°C. Subsequently, these plates were stored at 4°C for two
to three months. For transformations, C. albicans strains were picked from YPD plates and used
to inoculate 10 ml YPD (20 g/l peptone, 10 g/l yeast extract, 20 g/l glucose, pH 5). The cells
were incubated over night at 37°C, 180 rpm and at ambient CO2. For ribonucleic acid (RNA)
extractions, Als3 staining and microscopy, if not noted otherwise, two subsequent over night
cultures in synthetically dened glucose medium (SDG, 6.7 g/l yeast nitrogen broth (YNB)
without amino acids (Sigma, Taufkirchen), 20 g/l glucose, ph 5.0-5.5) at 37°C and 180 rpm
were diluted 1:100 in SDG, SDG + 10% human serum (Sigma-Aldrich, Taufkirchen) or synthe-
tically dened N-acetylglucosamine medium (SDN, 6.7 g/l YNB without amino acids, 20 g/l
N-acetylglucosamine). For medium switch, YPD over night cultures at 37°C were diluted 1:100
in Lee's (Lee et al., 1975), Spider (Liu et al., 1994), or Roswell Park Memorial Institute medium-
1640 (RPMI, Merck, Darmstadt). Over night cultures in M199 (Sigma, Taufkirchen, 9.5 g/l, ph 4,
37°C, 180 rpm, ambient CO2) were used to inoculate M199 (pH 4 or pH 8, 1:100). Incubation for
four to six hours at 37°C and ambient CO2 followed under shaking (180 rpm, RNA extraction,
GFP uorescence microscopy) or non-shaking (Als3 staining) conditions.
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2.5. Plasmid creation
For the creation of the pAHR1 -GAD w/o HA3-tag plasmid, the already published pAHR1 -
GAD plasmid was utilized (Schillig and Morschhäuser, 2013). With the primers 5'XhoI-AHR1
and 3'AII-GAD the AHR1 ORF fused to the Gal4 activator domain was amplied from the
pAHR1 -GAD plasmid and restriction sites were introduced. The resulting DNA band of appro-
ximately 2226 bp was excised from an agarose gel and cleaned up by gel extraction (QIAquick
Gel Extraction Kit, Qiagen, Hilden) according to the manufacturer's instructions. Next, the
DNA fragment was digested using the restriction enzymes XhoI and AII (both New England
Biolabs (NEB), Frankfurt a. M.) and again cleaned up via gel extraction. Next, the cleaned up
AHR1 -GAD insert was ligated into the linearized vector (pAHR1 -GAD backbone digested with
XhoI and AII, cleaned via gel extraction) using T4 DNA ligase and T4 DNA ligase buer (with
10 mM ATP, NEB, Frankfurt a. M.) at 16°C for 18 h.
2.6. E. coli transformation and plasmid extraction
For an E. coli transformation one vial of NEB Express competent E. coli (NEB, Frankfurt a.
M.) was thawed on ice for 30 min. To 27 µl of competent cells, 1.5 µl of ligated plasmid or
digested plasmid (negative control) was added. After another 30 min of incubation on ice, cells
were heat shocked for 20 s at 42°C and put on ice for 5 minutes. Subsequently, 500 µl super
optimal broth with catabolite repression outgrowth medium (NEB, Frankfurt a. M., preheated
to 30°C) was added to the cells and the mixture was incubated for 1 h at 37°C and 1200 rpm.
For each transformation approach 100 µl were plated on lysogeny broth selection plates (LB,
Carl Roth, Karlsruhe, 25 g/l + 20 g/l Agar) containing ampicillin (amp, 100 µg/m, Carl Roth,
Karlsruhe) and incubated over night at 37°C.
For initial screens, plasmids of colonies were extracted using a mini prep protocol. For this,
1 ml of E. coli over night culture in LB-amp was harvested and resuspended in ice-cold 250 µl
P1 buer (50 mM glucose, 1 M Tris, 10 mM EDTA, 5 µl/l RNase A (10 mg/l)). 250 µl P2
buer (200 mM NaOH, 1 % (v/v) SDS) was added. The mixture was incubated for 5 min at
room temperature (RT) with occasional inversion. Next, 250 µl P3 buer (2.55 M potassium
acetate, pH 4.8) was added and the reaction was mixed by inverting the tubes several times. The
suspension was centrifuged for 20 min at 16,000 x g and the supernatant was added to 750 µl
ice-cold isopropanol in order to precipitate the DNA. The mixture was inverted carefully and
centrifuged for 25 min at 16,000 x g. The supernatant was removed and the pellet was washed
once with 100 µl 70% ethanol. The pellet was air-dried and redissolved in 50 µl H2O. For large
scale harvest of plasmids the QIAgen plasmid midi kit (Qiagen, Hilden) was used according to
manufacturer's instructions. DNA pellets were resuspended in H2O instead of Tris-EDTA (TE)
buer.
2.7. C. albicans transformation
Transformations of C. albicans were performed using the the lithium acetate protocol (Walther
and Wendland, 2003). A YPD over night culture of C. albicans was used to inoculate 50 ml
YPD in a dilution of 1:100 or 1:50, depending on the density of the over night culture. After 4 h
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growth at 37°C shaking, the cells were harvested by centrifugation for 5 to 10 min at 4000 rpm.
The pellet was washed once with 50 ml distilled water and again centrifuged as described above.
In the meantime, sheared salmon sperm DNA (10 mg/ml, Thermo Fisher Scientic, Dreieich)
was heated up to 95°C for 15 minutes to part double strand DNA into single strand DNA and
put on ice. The cell pellet was taken up in 1 ml distilled water and transferred into a sterile
microcentrifuge tube. After centrifugation for 1 min at 13,000 x g, the pellet was resuspended in
0.75 to 1.5 ml freshly prepared lithium acetate solution (100 mM LiAc in 1 x TE), depending on
pellet size. For each transformation approach and negative control, 10 µl of salmon sperm DNA
was added to 100 µl cell solution, vortexed shortly and incubated for 2 to 3 min. Subsequently,
20 µl of the transformation cassette (plasmids digested as indicated in Tab. 2) and cleaned up by
gel extraction (QIAquick Gel Extraction Kit) or nothing (negative control) and 600 µl of freshly
prepared polyethylene glycol/lithium acetate solution (100 mM LiAc, 1 x TE, 40% PEG3640
(w/v, Sigma Aldrich, Taufkirchen)) was added to the cell solutions. The mixture was vortexed
rigorously and incubated for 15 to 18 h at 30°C. Afterwards, the cells were heat shocked for
15 min at 44°C and 1000 rpm. After 1 min on ice, the cells were harvested by centrifugation for
1 min at 13,000 x g and washed in 1 ml YPD. Centrifugation was repeated and the pellet was
resuspended in 10 ml YPD and incubated at 37°C shaking for 4 h. Finally, cells were harvested,
resuspended in 200 µl YPD and plated on selection plates. If SAT1 was used as selection marker,
YPD plates supplemented with 200 µg/ml nourseothricin (NTC, HKI, Jena) were used. If ARG4
was used as selection marker, cells were plated on SDG plates (6.7 g/l YNB without amino
acids, DIFCO, 20 g/l glucose, ph 5.0-5.5, 20 g/l agar-agar). Transformations were incubated for
2 to 3 days. Growing colonies were veried with colony polymerase chain reaction (PCR) and
corresponding primers displayed in Tab. 5.
2.8. Ribonucleic acid extraction
RNA extraction was performed using the phenol chloroform method, as already described (Martin
et al., 2013). In short, cells were grown under indicated conditions and harvested by centrifuga-
tion. The cell pellet was resuspended in 440 µl AE buer (50 mM sodium acetate, 10 mM EDTA
(pH 7), 1% SDS) and transferred to a new screw cap tube. After 30 s of thorough vortexing,
440 µl Phenol-Chloroform-Isoamylalkohol (acidic pH, Thermo Fisher Scientic, Dreieich) was
added and vortexing was repeated as described above. The solution was incubated for 5 min at
65°C and then incubated at -20°C for at least 30 min. Subsequently, the mixture was thawed for
5 min at 65°C and centrifuged for 2 min at full speed. The upper phase was transferred into a
new screw cap tube and one tenth volume of 3 M sodium acetate (pH 5.3) and one volume of
isopropanol were added. The mixture was carefully inverted and again frozen for at least 30 min
at -20°C. RNA was pelleted for 10 min at 12000 x g (RT), and washed twice with 70% ethanol.
Eventually, the RNA pellet was resuspended in 20 to 50 µl RNase-free water (depending on pellet
size). The RNA concentration was analyzed using the Agilent 2100 Bioanalyzer or the Nanodrop.
RNA was stored at -80°C.
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2.9. Reverse transcriptase quantitative polymerase chain reaction
The expression levels of certain genes under specic conditions in dierent C. albicans strains
was assessed with reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) ana-
lysis in biological triplicates. RT-qPCR was performed using the Brilliant III Ultra-Fast SYBR
Green RT-qPCR Master Mix (Agilent Technologies, Waldbronn) according to the manufacturer's
instructions. Reaction mixes for every well were prepared following this scheme:
1 µl 100 ng/µl RNA
0.2 µl dithiothreitol (RT)
5.8 µl H2O
1 µl primer 1
1 µl primer 2
1 µl RT/RNase Block (kept on ice)
10 µl SYBR Green 2x Master Mix (RT)











*measurement at the end of each cycle
**measurement after every ∆0.5°C
The relative expression levels were calculated using the ∆∆ct method (Pfa, 2001). In short,
Ct-values for the house-keeping gene ACT1 of each RNA sample were subtracted from the Ct-
values of genes of interest of the same RNA sample to generate the ∆Ct-value. Next, the Ct-value
of control RNA (wild type SC5314, 6 h in YPD at 37°C) was substracted from the ∆Ct-value to
create the ∆∆Ct-value. Finally, the relative expression was calculated by taking 2 to the negative
power of the ∆∆Ct-value.
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2.10. Als3 staining
500 µl of SDG resp. SDG with 10% human serum (H6914, Sigma-Aldrich, Taufkirchen) was
inoculated with 1x106 cells/ml or 1x105 cells/ml of C. albicans. Cells were incubated for 5 to
6 h in petri dishes with glass bottom (µDish, MoBiTec, Göttingen) at 37°C (no shaking). Cells
were then washed once with 1 x PBS. Subsequently, the cells were incubated for 1 h at RT with
a rabbit polyclonal antiserum raised against the recombinant N-terminal region of Als3 (Phan
et al. (2007), 0.7 mg/ml, 1:166 diluted in phosphate buered saline (PBS)). After one washing
step with PBS, incubation with a goat-anti-rabbit-488-immunoglobulin G (IgG, 1:250 diluted in
PBS, Jackson Immuno Research; Suolk, England) followed for 1 h at RT. Cells were washed
once with 1 x PBS, xed for 5 min at RT using 200 µl Histox (containing 4% formaldehyde,
Carl Roth, Karlsruhe) and then washed again three times. Finally, cells were stained with enough
calcouour white (1 g/l calcouor white, Remel BactiDrop, Thermo Fisher Scientic, Frankfurt
a. M.) volume to cover the whole dish surface for up to 10 min at RT. After one last washing
step with 1 x PBS, cells were ready for microscopy and stored at 4°C.
2.11. Microscopy
If not stated otherwise, the Axio-Observer.Z1 (Carl Zeiss, Jena) was used for dierential interfe-
rence contrast (DIC) and uorescence microscopy in the green uorescing protein (GFP) channel.
Standard excitation time of 1700 ms for GFP detection was used.
Micrographs of the invasion assay were taken with the same microscope in DIC, GFP and 4',6-
diamidino-2-phenylindole (DAPI) channels. For Als3-staining microscopy, the Laser scanning




Frame size: x=1024; y=1024 (Optimal)
Avergeing:
Number: 4










405 Laser (DAPI, Range: 410-473nm, for Calcoour white detection)
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Z-stacks were taken of hyphal and pseudohyphal cells. For image processing the Zen blue soft-
ware was used. Z-stacks were merged using the method Sharpen → Extended Depth of Focus
→ Method → Maximum Projection (only A488 and DAPI display). In the merged Z-stacks or
the images of yeast cells, which were taken only on one focal plane, the histogram settings were
changed from white 65.535 to 30.000 for a brighter signal.
2.12. Measurement of secreted Candidalysin
The Candidalysin secreted into the culture supernatant was processed and measured by S. Mo-
gavero of the group Microbial Pathogenicity Mechanisms (MPM) and T. Krüger from the group
Molecular and Applied Microbiology (MAM) at the Hans-Knöll-Institute (HKI). For this, in-
dicated strains were grown for 18 h in either yeast (YNB medium with 2% sucrose, pH 4) or
hyphae (YNB medium with 2% sucrose, 75 mM 2-hydroxy-3-morpholinopropanesulfonic acid
(MOPSO) buer, pH 7.2, 5 mM GlcNac) inducing medium at 37°C and 180 rpm, starting at an
OD600 of 0.05. Subsequently, supernatants were collected, processed and further analyzed by li-
quid chromatography-mass spectrometer/mass spectrometer system (Ultimate 3000 nano RSLC
system coupled to a QExactive Plus mass spectrometer) as previously described (Moyes et al.,
2016).
2.13. Lactate dehydrogenase (LDH) assay
LDH assays were carried out at the laboratories of the MPM department at the HKI with the
help of Rita Müller and Stefanie Allert. 2x104 TR146 buccal epithelial carcinoma cells in 200 µl
Dulbecco's Modied Eagle Medium (DMEM)/F12 (Gibco; Thermo Fisher Scientic, Frankfurt a.
M.) + 10% heatinactivated fetal bovine serum (FBS) were seeded into the wells of 96-well plates
and incubated for 1 to 2 days at 37°C 5% CO2, until a conuent monolayer could be observed
under the microscope. Over night cultures (YPD, 30°C, 180 rpm) of sought out C. albicans
strains were used for infection. They were washed twice with PBS and counted in a Neubauer
counting chamber. A stock solution of 4x105 cells per ml DMEM/F12 was generated. The medium
was removed from the prepared TR146 cells in the 96-well plates and 100 µl fresh DMEM/F12
(without FBS) was added (200 µl for low and high control). 100 µl of the C. albicans stock
solutions were added to the wells in triplicates, so that 4x104 cells were added per well. Incubation
at 37°C and 5% CO2 followed. After 24 h, 10 µl 5% Triton-x 100 was added to the high control
wells and the plate was again incubated for 10 min at 37°C and 5% CO2. The plate was then
centrifuged at 250 x g for 5 min. Subsequently, 10 µl of each supernatant was added to 90 µl
of PBS in new wells. Lactatedehydrogenase (Roche, Mannheim) from rabbit muscle was used to
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generate a standard curve. Supernatant from uninfected TR146 cells served as a 'low control'.
Supernatant from Triton-x 100 treated cells was used as 'high control'. The release of LDH was
measured using the Cytotoxicity Detection Kit (LDH) (Roche, Mannheim), according to the
manufactorer's instructions. In short, 100 µl of freshly prepared LDH-Kit solution was added to
each well. The mixture was incubated 10 to 15 min in the dark at RT. The reaction was stopped by
the addition of 50 µl 1 M hydrochloric acid (HCL). The absorption at the wavelengths of 490 nm
(LDH assay) and 660 nm (background) was measured using a plate reader. The absorbance at
660 nm was subtracted from the absorbance at 490 nm. The calculated value was used for further
analyses. The measured value for the low control was subtracted from all values. To evaluate
the % cytotoxicity, this value was then divided by the value of the high control and multiplied
by 100.
2.14. Invasion assay
The invasion assay was carried out with the help of Rita Müller and Stefanie Allert at the labo-
ratories of the MPM department at the HKI in Jena. 1x105 TR146 cells in 250 µl DMEM/F12 +
10% heatinactivated FBS were seeded into each well of a 24-well plate with coverslip and in-
cubated for 1-2 days at 37°C 5% CO2, until a conuent monolayer was built up. Over night
cultures (YPD, 30°C, 180 rpm) of sought out C. albicans strains were used for infection. They
were washed twice with PBS, counted in a Neubauer counting chamber and stock solutions of
4x105 cells/ml in DMEM/F12 were created. The medium of the TR146 cells in the 24-well plate
was removed and replaced with 250 µl of the stock solutions, so that each well was infected
with 1x105 cells. Subsequently the plates were incubated for 4 h at 37°C and 5% CO2. Next,
the cells were carefully washed twice with PBS for 1 min each to remove non-adherent cells.
Fixation with 400 µl Histox per well followed at 4°C over night. Then, the cells were washed
twice in PBS for one minute each. For outside staining, cells were incubated with 200 µl/well
Concanavalin A solution (5 mg/ml stock 1:500 in PBS) for 1 h at 30°C in the dark. Two washing
steps with PBS for one minute each followed. Subsequently, cells were permeabilized by adding
300 µl 0.5% triton-x per well for 5 min at RT. Washing with PBS was repeated three times.
For inside staining, 400 µl 0.01-0.035 mg/ml calcouor white in Tris-HCl (0.1 M, pH 9.0) were
added per well and incubation for 20 min at RT in the dark followed. Cells were washed three
times for 10 min in 1 ml bidistilled water at 30°C. Coverslides were removed from the wells and
invertedly mounted on a microscope slide with about 5 µl mounting medium. Slides were stored
at 4°C prior to microscopic analysis with the Axio-Observer.Z1 (Carl Zeiss, Jena).
2.15. Chromatin Immuno Precipitation DNA Sequencing (ChIP-Seq)
A protocol for formaldehyde xation was provided by the company Active Motif, which performed
the Chromatin Immuno Precipitation DNA Sequencing (ChIP-Seq) analysis. For this, strains of
interest (SC5314+AHR1-GAD and SC5314+AHR1-GAD w/o HA-tag as negative control, ref.
no. 177 and 427) were grown in double over night cultures in two times 20 ml SDG medium
at 37°C shaking. On the third day, two times 250 ml prewarmed SDG medium was inoculated
with 7.5 ml double over night culture each and incubated shaking at 37°C (1:33.3). After six
hours of incubation, falcon tubes lled with 3.12 ml 16% formaldehyde (methanol-free, Thermo
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Fisher Scientic, Frankfurt a. M.) were lled up to 50 ml with the SDG cultures. The tubes were
inverted several times during a total incubation time of 15 min at RT. The xation procedure
was stopped with the addition of 2.5 ml 2.5 M glycine solution. The reaction was inverted several
times during a subsequent incubation of 5 min at RT. Cells were centrifuged at 4,000 x g for
10 minutes at 4°C and the supernatant was removed. From now on, cells were kept on ice. Pellets
were resuspended in 10 ml chilled PBS-Igepal (PBS, nal conc. of 0.5% Igepal) and pellets from
the same strains were pooled. The cells were again centrifuged as described above and the pellets
were resuspended in 10 ml chilled PBS-Igepal and 100 µl phenylmethylsulfonyl uoride (100 mM
in ethanol, nal conc. 1 mM). Cells were centrifuged again and pellets were snap-frozen in liquid
nitrogen and stored at -80°C. Formaldehyde xed pellets were sent for further ChIP-Seq analysis
to Active Motif. The mutant without the HA3-tag was important for the antibody validation.
ChIP-Seq reads were analyzed by Active Motif including peak calling and peak ltering resulting
in 325 peaks. The peak data was further analysed by Daniela Albrecht-Eckardt from BioControl
Jena GmbH. Using the chromosomal position of the peaks, neighboring genes on both forward
and backward strands were identied in the genome. A sequence of 500 nucleotides centering
at the maximum of each peak region was extracted. These 325 sequences were used as input
for the online motif analysis tool Meme-ChIP (v. 5.1.0, Machanick and Bailey (2011)). Default
parameters with background Markov model generated from the supplied sequences were chosen
and searched for motifs with a length of 8 to 20 base pairs (bp). The identied motif was conrmed
by the motif nder utility of MochiView (v. 1.46, Homann and Johnson (2010)). The Integrated




3.1. Ahr1 is a regulator of ECE1 expression
3.1.1. Identication of possible activators of ECE1 expression
One of the most strongly upregulated genes in the C. albicans hyphae is ECE1. To identify
transcription factors which play a role in the activation of ECE1 expression, the 5' intergenic
region of ECE1 was examined. It is made up of 3197 base pairs and contains several possible
binding sites of known activators of hyphal growth. An in silico analysis showed that Bcr1,
Cph1 and Tec1 possess one, Fkh2 two, Ahr1, Brg1, Mcm1 and Ume6 three, Ndt80 six and Efg1
15 possible binding sites in the 5' intergenic region, as displayed schematically in Fig. 2. For a
detailed list of the exact motifs and locations see Tab. VII (Sec. VII).
Fig. 2: Schematic display of putative transcription factor binding sites in the 5` in-
tergenic region of ECE1.
The transcription factors Ahr1, Bcr1, Brg1, Cph1, Efg1, Fkh2, Mcm1, Ndt80, Tec1 and
Ume6 possess possible binding sites upstream of the ECE1 open reading frame (ORF).
3.1.2. Screen of activator mutants reveals that Ahr1 is necessary for high-level ECE1
expression in hyphal morphology
Deletion mutants of the transcription factors mentioned in Sec. 3.1.1 were tested for their inu-
ence on ECE1 expression under hypha-inducing conditions (strain no.: 127, 128, 147, 148, 201,
81, 78, 207, 504, 150 and 129, see Tab. 1). No deletion mutant of MCM1 was available, since the
gene is essential (Rottmann et al., 2003). A cph1∆/efg1∆ mutant was included into the screen,
since both transcription factors possess possible binding sites in the ECE1 5' intergenic region.
Furthermore, the double mutant is known for being locked in the yeast growth state. For the
screen, the GFP gene was transformed into the ECE1 locus of these mutants to visualize ECE1
expression (GFP reporter system). Figure 3A shows micrographs of the GFP reporter strains
taken 4 h after hyphal induction in SDG with 10% human serum at 37°C. The cph1∆ and fkh2∆
mutants displayed normal hyphal formation and a wild type-like GFP signal. The bcr1∆ mutant
showed a mixture of green uorescing hyphae and not or only faintly uorescing pseudohyphal
cells (Fig. 3A). This suggests, that binding of Cph1, Fkh2 and Bcr1 to their possible binding sites
in the 5' intergenic region, was not necessary for ECE1 expression under the tested conditions.
The ume6∆ mutant only displayed pseudohyphal growth. Nevertheless, as indicated in Fig. 3A,
a GFP signal could be observed from these pseudohyphae. 53% (n=366) of brg1∆ cells showed
no, and 47% (n=326) a faint or strong GFP signal. The morphologies of brg1∆ cells after hy-
phal induction varied between yeast cells, short laments and pseudohyphae. Interestingly, 50%
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(n=488) of the efg1∆ yeast cells showed a GFP signal, while the cph1∆/efg1∆ yeasts did not
exhibit any GFP signal. The ndt80∆ and the tec1∆ mutants did not form hyphae and displayed
no or only a faint GFP signal, as depicted in Fig. 3A. An abnormal growth of theses mutants
could be due to a variety of dysregulated transcription mechanisms. Since a direct regulator of
ECE1 expression in the hyphal morphology was wanted, these mutants were disregareded for
further analyses. From the screened mutants, only the ahr1∆ mutant was able to form phenoty-
pically normal hyphae while showing no or only a faint GFP signal (Fig. 3A). Due to this, Ahr1
was an interesting candidate for a possible direct regulation of the ECE1 transcription.
In order to verify these results concerning ECE1 expression, RNA of wild type and deletion
mutants (strain no. 94, 95, 141, 143, 261, 349, 4, 104, 196, 261, 145 and 12, see Tab. 1) was
extracted after 4 h growth in SDG with 10% human serum (Fig. 3B). In accordance to the GFP
reporter assay, relative expression of ECE1 in the cph1∆ and the fkh2∆ mutants was similar to
that of wild type hyphae, as depicted in Fig. 3B.
Fig. 3: The transcription factor Ahr1 is important for ECE1 expression in Candida
albicans hyphae.
AWild type and regulatory mutants with the GFP reporter system, where the GFP gene
was integrated into the ECE1 locus, were grown for 4 h in SDG with 10% human serum
at 37°C prior to microscopy. DIC and GFP channel were merged. Bar=10 µm.
B Total RNA of wild type and regulatory mutants was isolated after 4 h growth in SDG
with 10% human serum in biological triplicates. 100 ng/µl of this RNA was used for
RT-qPCR to determine the relative gene expression of ECE1. Data was normalized to
a control RNA (wild type, 6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks




All other mutants showed a signicant reduction in ECE1 expression, with the bcr1∆, the efg1∆
and the ume6∆ mutants having higher and the brg1∆, the cph1∆/efg1∆, the tec1∆ and the
ndt80∆ mutants having lower ECE1 expressions than the ahr1∆ hyphae (Fig. 3B). These results
supported the ndings of the GFP reporter assay.
3.2. Ahr1 is important for Candidalysin secretion
As shown above, ECE1 expression was signicantly downregulated in an ahr1∆ mutant compa-
red to wild type under hyphal growth conditions. The question arose whether this downregula-
tion was associated with a decrease in Candidalysin secretion. Following an already established
protocol (Moyes et al., 2016), S. Mogavero and T. Krüger (both: Hans-Knöll-Institute, Jena),
measured the amount of secreted Candidalysin by the wild type and the ahr1∆ mutant (strain
no. 1 and 95, Tab. 1) after 18 h growth in hyphae-inducing medium (YNBS, pH 7.2, 37°C) using
LC-MS/MS. Results depicted in Fig. 4A show that the amount of detected peptides that mat-
ched to Candidalysin (PSM=peptide spectrum matches) was with 68 PSM indeed lower in the
ahr1∆ mutant compared to 345 PSM in the wild type. A detailed listing of measured peptides
can be see in Tab. 7 (Sec. VII).
Fig. 4: Ahr1 is important for Candidalysin secretion of C. albicans.
Wild type and the ahr1∆ mutant were incubated for 18 h under hyphal growth conditions
(YNBS, pH 7.2, 37°C). Candidalysin was extracted from supernatant and measured by
LC-MS/MS. PSM= peptide spectrum matches.
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3.3. Hyperactive Ahr1 induces high-level ECE1 expression
3.3.1. Hyperactive Ahr1 induces ECE1 expression in wild type and independent of Cph1
and Efg1 under yeast growth conditions
For further elucidating the role of Ahr1 in terms of ECE1 expression, we transformed a hyperac-
tive Ahr1 into the ADH1 locus of dierent C. albicans strains. Schillig and Morschhäuser found
that by C-terminal fusion of a zinc cluster transcription factor to a heterologous Gal4 activator
domain (GAD), an articial activation of the transcription factor could be achieved (Schillig and
Morschhäuser, 2013). Integration of such an AHR1 -GAD allele into a C. albicans strain with the
ECE1 -promotor driven GFP (strain no. 127 and 154, Tab. 1) was able to induce a GFP signal in
cells, already under yeast growth conditions, as can be seen in Fig. 5A. Additionally, it increased
clustering of cells and resulted in a more elongated morphology or even pseudohyphae formation
(Fig. 5A). This correlated to a signicant increase in relative ECE1 expression after 4 h growth
under yeast growth conditions (strain no. 1 and 177, Tab. 1), as shown in Fig. 5B. This ECE1
Fig. 5: Hyperactive Ahr1 induces ECE1 expression under yeast growth conditions
and independent of Cph1 and Efg1.
A A hyperactive Ahr1 was transformed into the ADH1 locus of the C. albicans wild type
(including ECE1 promotor-driven GFP system, pECE1 -GFP) and the cph1∆/efg1∆
mutant. Cells were grown for 4 h in SDG with or without 10% human serum at 37°C
prior to microscopy. DIC and GFP channels were merged. Bar=10 µm.
B Total RNA of the wild type and the cph1∆/efg1∆mutants with or without hyperactive
Ahr1 was isolated after 4 h growth in SDG with or without 10% human serum in biological
triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the relative gene
expression of ECE1. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C)
and the housekeeping gene ACT1. Asterisks mark signicant dierences of hyperactive




expression was comparable to that of wild type hyphae.
Cph1 and Efg1 are known activators of hyphal growth and the cph1∆/efg1∆ double mutant
is nonlamentous under most hyphae-inducing conditions. ECE1 expression in this mutant was
signicantly decreased compared to the wild type under hyphal growth conditions (Fig. 3B).
Integration of a hyperactive Ahr1 into the cph1∆/efg1∆ mutant resulted in clustering and elon-
gation of some cells in yeast growth medium and pseudohyphae formation of some cells after
serum-induction (strain no. 104 and 157, Tab. 1, Fig. 5A). Due to a lack of available selection
markers for further transformation of the double mutant, it was not possible to additionally
examine the ECE1 GFP reporter system in these strains. RT-qPCR results, revealed that a
hyperactive Ahr1 was able to induce ECE1 expression in the cph1∆/efg1∆ mutant under yeast
and hyphal growth conditions up to the level of wild type hyphae (strain no. 104 and 157, Tab. 1,
Fig. 5B). This observation indicated, that the mechanism by which a hyperactive Ahr1 induced
ECE1 expression was independent from Cph1 and Efg1 and environmental stimuli like human
serum.
3.3.2. Hyperactive Ahr1 increases Candidalysin secretion
Due to the signicantly increased ECE1 expression in the wild type and the cph1∆/efg1∆
mutant with hyperactive Ahr1, it was further tested if this increased transcription correlated
with an increased Candidalysin secretion. The wild type and the cph1∆/efg1∆ mutants with
and without hyperactive Ahr1 were grown for 18 hours under yeast (YNBS, pH 4, 37°C) or hyphal
(YNBS, pH 7.2, 37°C) growth conditions (strain no. 1, 177, 104 and 157, Tab. 1). Candidalysin
measurement followed as described above. Surprisingly, elevated ECE1 expression under yeast
growth conditions of the wild type and the cph1∆/efg1∆ mutant due to a hyperactive Ahr1,
did not result in an increase in Candidalysin secretion as depicted in Fig. 6. Small amounts of
secreted Candidalysin were detected in the cph1∆/efg1∆ mutants with or without hyperactive
Ahr1 under yeast growth conditions. A possible explanation for this is the contamination of
the LC column (see also tab. 7, section VII). Since the Ece1-III peptide is very sticky, washing
steps in between measuring dierent samples potentially did not suce to completely remove
the peptide. Subsequently, ECE1-III peptides sticking to the LC column could have led to false
positives.
Under hyphal growth conditions, a hyperactive Ahr1 was able to elevate the amount of detected
Candidalysin (Fig. 6). Interestingly, due to a hyperactive Ahr1 secreted Candidalysin levels in
the wild type background rose from 345 to 612 PSM under hyphal growth conditions (Fig. 6),
even though ECE1 expression was not signicantly increased after 4 h serum induction (cf. Fig.
5B). In the cph1∆/efg1∆ mutant Candidalysin secretion increased from 0 to 352 PSM due to
the hyperactive Ahr1 (Fig. 6), which correlates to ECE1 expression data (cf. Fig. 5B).
More detailed information about the results of the peptide measurement can be found in Tab. 7
(Sec. VII). Summing up, even though a hyperactive Ahr1 was able to signicant increase ECE1
expression in the wild type and the cph1∆/efg1∆ mutant, an increase in Candidalysin secretion
was only detectable under hyphal growth conditions. This indicates that proper hyphae formation
is crucial for correct processing of Ece1 and Candidalysin secretion.
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Fig. 6: Hyperactive Ahr1 increases Candidalysin secretion under hyphal-growth con-
ditions in C. albicans.
Wild type and the cph1∆/efg1∆ mutants with or without hyperactive Ahr1 were incu-
bated for 18 h under yeast (YNBS, pH 4, 37°C) or hyphal (YNBS, pH 7.2, 37°C) growth
conditions. Candidalysin was extracted from supernatant and measured by LC-MS/MS.
PSM= peptide spectrum matches.
3.3.3. Hyperactive Ahr1 only leads to slight increase of cytotoxicity of the ahr1∆ and the
cph1∆/efg1∆ mutants
Candidalysin is a toxin and, upon secretion from C. albicans hyphae, directly damages epithelial
membranes (Moyes et al., 2016). The secretion of Candidalysin could be increased in the wild type
and the cph1∆/efg1∆ mutant with hyperactive Ahr1 (Fig. 6). Accordingly, the ability to induce
damage should be increased due to a hyperactive Ahr1. To investigate this, LDH release assays
were performed with the help of Stefanie Allert and Rita Müller (both: HKI, Jena). Therefore,
the wild type and the ahr1∆ and the cph1∆/efg1∆ mutants with and without hyperactive
Ahr1 were coincubated with TR146 buccal epithelial carcinoma cells for 24 h (strain no. 1, 177,
104, 157, 271 and 517, Tab. 1). Subsequently, the release of LDH was measured. Cytotoxicity
of each strain was calculated in relation to uninfected, triton-x killed TR146 cells. The result is
displayed in Fig. 7. In accordance to the ECE1 transcription (cf. Fig. 3 and 5) and Candidalysin
secretion data (cf. Fig. 6 and 4), the cytotoxicity of the ahr1∆ and the cph1∆/efg1∆ mutants
was signicantly lower compared to the wild type. This correlates to already published data
(Allert et al., 2018; Lo et al., 1997). In the wild type background, no additional damage was
induced due to a hyperactive Ahr1. This could be due to fact that a certain (wild type) level
of Candidalysin was sucient to induce damage to host cells. A hyperactive Ahr1 was able to
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increase the cytotoxicity of the ahr1∆ mutant from 16.6% to 36.4% and in the cph1∆/efg1∆
mutant from 3.0% to 23.4%. However, these increases were not signicant.
Fig. 7: Cytotoxicity of the wild type and the ahr1∆ and the cph1∆/efg1∆ mutants
with and without hyperactive Ahr1.
TR146 cells were coincubated with wild type and the ahr1∆ and the cph1∆/efg1∆
mutants with and without hyperactive Ahr1 for 24 h. Cell damage was quantied by
LDH release assay. Cytotoxicity of each strain was calculated in relation to uninfected
cells killed with triton-x. The assay was performed in triplicates and values of three
independent experiments were combined. Asterisks mark signicant dierences (*p ≤0.05,
two tailed, unpaired student's t-test).
3.3.4. Mutants lacking AHR1 or CPH1 and EFG1 can still invade epithelial cells
Due to a low cytotoxicity of the ahr1∆ and the cph1∆/efg1∆ mutants, which could not be
signicantly increased via a hyperactive Ahr1, the ability of the mutants to invade TR146 was
analyzed. Therefore, TR146 cells were infected with wild type, ahr1∆ and cph1∆/efg1∆ cells
with and without the hyperactive Ahr1 (strain no. 1, 177, 104, 157, 271 and 517, Tab. 1). After
4 h growth at 37°C and 5% CO2, non-adherent fungal cells were washed away. Extracellular
C. albicans cells were stained with concanavalin A conjugated to uorescein (Fig. 8, red). Subse-
quently, cells were permeabilized and whole fungal cells were stained using calcouor white (Fig.
8, blue). Fluorescence microscopy revealed that not only wild type but also the ahr1∆ and the
cph1∆/efg1∆ mutants were able to invade TR146 cells (Fig. 8, arrows mark points of invasion).
Since the fungal cells were alive and not xed for the invasion assay, it can not be excluded
that the fungi were endocytosed by the epithelial cells. Interestingly, the cph1∆/efg1∆ mutant
formed elongated cells after incubation on TR146 cells. Unsurprisingly, a hyperactive Ahr1 did
not inuence the ability to invade TR146 cells (Fig. 8) but did lead to further elongation of
cph1∆/efg1∆ cells under these conditions. While 37% of counted wild type cells were invasive
(total n=421), 44% of the cph1∆/efg1∆ cells (total n=200) and 50% of the ahr1∆ (total n=562)
cells were invading epithelial cells. This was unexpected and contradictory to prior experiments
(cf. Fig. 7). However, at least for the wild type and the cph1∆/efg1∆ mutant, it can be ex-
plained with a general decreased ability of the deletion mutant to adhere to epithelial cells. On
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Fig. 8: Invasion capacities are not inhibited in the ahr1∆ and the cph1∆/efg1∆ mu-
tants.
C. albicans wild type and the cph1∆/efg1∆ and the ahr1∆ mutants with or without
hyperactive Ahr1 were coincubated with TR146 cells at 37°C and 5% CO2. After 4 h,
extracellular C. albicans cells were stained with concanavalin A conjugated to uorescein
(red). Subsequently cells were permeabilized and whole C. albicans cells were stained
with calcouor white (blue). An overlay of the DIC, the GFP (red) and the DAPI (blue)
channel is displayed. Arrows indicate points of invasion of C. albicans cells into TR146
cells. Bar=10 µm.
average 359 wild type but only 32 cph1∆/efg1∆ cells were counted per mm2 coverslip (cells
on 4 mm2 coverslip were counted per strain). Probably, those adherent cph1∆/efg1∆ cells only
adhered because they were invading or endocytosed by the epithelial cells. Due to this, further
quantication of invasive cells with hyperactive Ahr1 was not performed.
3.3.5. Hyperactive Ahr1 induces ECE1 expression independent of Ume6, Tec1, Ndt80 and
Brg1
A screen of activator mutants (see section 3.1.2) revealed that not only in the cph1∆/efg1∆
and the ahr1∆ but also in the ume6∆, the tec1∆, the ndt80∆ and the brg1∆ mutants ECE1
expression was signicantly downregulated compared to the wild type. Additionally, morphology
under hyphae-inducing conditions varied from that of the wild type. Thus, it was investigated
whether the ability of the hyperactive Ahr1 to induce ECE1 expression was dependent on one of
these transcription factors. Further on, microscopy should reveal if the hyperactive Ahr1 changed
the morphology of these mutants in a similar fashion as in the wild type and the cph1∆/efg1∆
mutant. A hyperactive Ahr1 did not have an inuence on the morphology of the ume6∆ and the
tec1∆ mutants after 4 h incubation in SDG (strain no. 12, 214, 145 and 150, Tab. 1, Fig. 9A).
For the ndt80∆ and the brg1∆ mutants, a hyperactive Ahr1 led to the elongation and increased
the clustering of yeast cells, as shown in Fig. 9A and C (strain no. 374, 504 and 143, 148, Tab. 1).
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An ECE1 promotor driven GFP reporter system was transformed into the brg1∆ mutant with
and without hyperactive Ahr1. Already under yeast growth conditions a bright GFP uorescence
was visible in the mutant with hyperactive Ahr1 (Fig. 9C). After 4 h of hyphal induction with
10% human serum, the ume6∆ mutant was able was form short laments (Fig. 9A). It is already
known that this mutant is unable to extent hyphal formation (Carlisle and Kadosh, 2010).
Fig. 9: Hyperactive Ahr1 induces ECE1 expression independent of Ume6, Tec1,
Ndt80 and Brg1.
Micrographs of the ume6∆, the tec1∆, the ndt80∆ (A) and the brg1∆ mutants (with
GFP reporter system, C) with or without hyperactive Ahr1. Strains were grown for 4 h
in SDG with or without 10% human serum prior to microscopy. Bar=10 µm.
Total RNA of the wild type and the ume6∆, the tec1∆, the ndt80∆ mutants (B) and
the wild type and the brg1∆ mutants (with GFP reporter system, D) with or without
hyperactive Ahr1 was isolated after 4 h growth in SDG with or without 10% human se-
rum in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine
the relative expression of ECE1. Data was normalized to a control RNA (wild type, 6
h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dierences
of hyperactive Ahr1 mutants compared to the respective parental strain (*p ≤0.05, two
tailed, unpaired student's t-test).
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In contrast to this, the ume6∆ mutant with hyperactive Ahr1 only grew as yeast after 4 h serum
induction, as depicted in Fig. 9A. The mutant lacking TEC1 with or without hyperactive Ahr1
was only able to form pseudohyphae under hyphal growth conditions. After serum induction,
the ndt80∆ mutant formed short elongated cells, which regularly branched o. This correlated
to already published data (Sellam et al., 2009). A hyperactive Ahr1 in the ndt80∆ background
led to increased elongation of cells but only pseudohyphae and no true hyphae formation. While
only a faint GFP signal was visible in some brg1∆ laments, the brg1∆ mutant with hyperactive
Ahr1 showed a bright GFP uorescence under hyphal growth conditions (Fig. 9C).
As shown in Figures 9B and D, RT-qPCR analyses revealed that a hyperactive Ahr1 was able to
signicantly increase ECE1 expression in all of these mutants up to or close to wild type level
expression under hyphae-inducing but also non-inducing conditions (strain no. 266, 145, 374,
380, 12, 215, 262 and 148, Tab. 1). For the brg1∆ mutants with and without hyperactive Ahr1,
strains with the GFP reporter system were analysed. Since the GFP gene was transformed into
the ECE1 locus in these mutants, a wild type which also possessed the GFP reporter system
was used as control. The analyses indicate that the mechanism by which the hyperactive Ahr1
induces ECE1 expression is independent of the transcription factors Ume6, Tec1, Ndt80 and
Brg1.
3.3.6. Hyperactive Ahr1 has no eect on ECE1 expression in the tup1∆ mutant
It was shown that a hyperactive Ahr1 is able to induce ECE1 expression in wild type C. albicans
cells even without the usual hyphal induction by human serum (cf. Fig. 5). This signicant
increase in expression was independent from several transcription factors with possible binding
sites in the 5' intergenic region of ECE1 (cf. Fig. 5 and 9). It has already been postulated that
Tup1 may play a regulating role in C. albicans hyphae (Garbe, 2016). The question arose whether
a hyperactive Ahr1 was able to induce ECE1 expression in the absence of Tup1. Therefore, the
hyperactive Ahr1 was transformed into a tup1∆ mutant with the ECE1 -promotor-driven GFP
reporter system.
Fig. 10A illustrates that after 4 h growth in yeast and hyphal growth medium, a hyperactive Ahr1
had no benecial eect on the GFP signal in the absence of Tup1 (strain no. 94, 127, 116 and
132, Tab. 1). The same phenomenon was observed in RT-qPCR analysis displayed in Fig. 10B
(strain no. 1, 177, 14 and 438, Tab. 1). Even though ECE1 expression of the tup1∆ mutant was
higher than in the wild type under yeast growth conditions, ECE1 expression could neither be
elevated due to incubation with human serum nor due to a hyperactive Ahr1 (Fig. 10B). This
suggests that the function of a hyperactive Ahr1 is dependent on Tup1, a known repressor of
hyphal growth, for high level expression of ECE1. Corresponding to the low ECE1 expression of
the tup1∆ mutant, Candidalysin secretion of this mutant was much lower than in the wild type
after 4 h serum-induction, as depicted in Fig. 10C.
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Fig. 10: Hyperactive Ahr1 depends on Tup1 for induction of high-level ECE1 expres-
sion.
A Wildtype and tup1∆ with ECE1 -promotor-driven GFP and with or without hype-
ractive Ahr1 were incubated for 4 h in SDG with or without 10% human serum prior to
microscropy. Images from the DIC and the GFP channel were merged. Bar=10 µm.
B Total RNA of the wild type and the tup1∆ mutants with or without hyperactive Ahr1
was isolated after 4 h growth in SDG with or without 10% human serum in biological
triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the relative gene
expression of ECE1. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C)
and the housekeeping gene ACT1. Asterisks mark signicant dierences of hyperactive
Ahr1 mutants compared to the respective parental strain (*p ≤0.05, two tailed, unpaired
student's t-test).
C Wild type and the tup1∆ mutant were incubated for 18 h under hyphal growth
conditions (YNBS pH 7.2, 37°C). Candidalysin was extracted from supernatants and
measured by LC-MS. PSM= peptide spectrum matches.
3.4. Ahr1 activates expression of core lamentation response genes
3.4.1. Ahr1 is important for the expression of other core lamentation response genes in
hyphae
Upon hyphal formation of C. albicans a certain set of core lamentation response (CFR) genes is
upregulated (Martin et al., 2013). Knowing that Ahr1 plays an important role in the regulation
of ECE1, it was determined if this transcription factor also played a role in the expression of
other CFR genes.
RT-qPCR analyses of RNA extracted after 4 h growth at 37°C in SDG with 10% humans serum
suggest that Ahr1 was also important for high-level expression of ALS3, DCK1, HGT2, HWP1,
IHD1 and orf19.2457 (strain no. 1 and 271, Tab. 1, Fig. 11). Interestingly, RBT1 expression was
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signicantly increased in the ahr1∆ mutant compared to the wild type. Summing up, Ahr1 has
an inuence on the expression of several CFR genes under hyphae-inducing conditions.
Fig. 11: Ahr1 is important for the expression of core lamentation response genes in
C. albicans hyphae.
Total RNA of the wild type and the ahr1∆ mutant was isolated after 4 h growth in SDG
with 10% human serum in biological triplicates. 100 ng/µl of this RNA was used for RT-
qPCR to determine the relative gene expression of ALS3, DCK1, ECE1, HGT2, HWP1,
IHD1, RBT1 and orf19.2457. The data was normalized to a control RNA (wild type,
6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dierences
between the wild type and the ahr1∆ mutant (*p ≤0.05, two tailed, unpaired student's
t-test).
3.4.2. Hyperactive Ahr1 is able to induce the expression of other core lamentation
response genes independent of Cph1 and Efg1
As shown earlier, Ahr1 was important for the expression of other core lamentation response
genes (Fig. 11) and a hyperactive Ahr1 was able to induce ECE1 expression in the wild type
background and the cph1∆/efg1∆ mutant (Fig. 5). Due to this, it was investigated whether
the hyperactive Ahr1 was also able to inuence the expression of the other CFR genes. Indeed,
a hyperactive Ahr1 was able to signicantly induce ALS3, HWP1 and IHD1 expression in the
wild type, independent of Cph1 and Efg1 and already under yeast growth conditions (strain no.
1, 177, 104 and 157, Tab. 1, Fig. 12). For HGT2, RBT1, DCK1 and orf19.2457 this pattern
could not be observed. A hyperactive Ahr1 was able to signicantly induce HGT2 expression
in the wild type in yeast growth conditions. However, under hyphal growth conditions HGT2
expression was signicantly reduced in a wild type with hyperactive Ahr1. This was also true
for RBT1 and DCK1 expression. Additionally, RBT1 and DCK1 expressions were signicantly
increased in the cph1∆/efg1∆ double mutant with hyperactive Ahr1 under yeast growth condi-
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tions. orf19.2457 expression was signicantly increased in the wild type with hyperactive Ahr1
under yeast growth conditions. Apart from this, a hyperactive Ahr1 did not have an inuence
on orf19.2457 expression.
Fig. 12: Hyperactive Ahr1 induces expression of ALS3, HWP1 and IHD1 indepen-
dent from Cph1/Efg1.
Total RNA of the wild type and the cph1∆/efg1∆ mutants with and without hyperac-
tive Ahr1 was isolated after 4 h growth in SDG with and without 10% human serum in
biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the
relative gene expression of ALS3, HWP1, IHD1, HGT2, RBT1, DCK1 and orf19.2457.
Data was normalized to a control RNA (wild type, 6 h YPD, 37°C) and the house-
keeping gene ACT1. Asterisks mark signicant dierences of hyperactive Ahr1 mutants




3.4.3. Hyperactive Ahr1 relies on Tup1 for the induction of high-level ALS3 expression
A hyperactive Ahr1 was able to induce the expression of ALS3 in a Cph1/Efg1- and stimulus-
independent manner (cf. Fig. 12). To analyze whether this induction is dependent on TUP1, as it
was shown earlier for ECE1 expression (cf. Fig. 10), RNA was extracted from the wild type and
the tup1∆ mutants with and without hyperactive Ahr1 (strain no. 1, 177, 14, 438, Tab. 1) after
4 h incubation in SDG with or without 10% human serum at 37°C. Interestingly, a hyperactive
Ahr1 was not able to increase ALS3 expression in tup1∆, as illustrated in Fig. 13.
Fig. 13: Hyperactive Ahr1 depends on Tup1 for induction of high-level ALS3 expres-
sion.
Total RNA of the wild type and the tup1∆ mutants with or without hyperactive Ahr1
was isolated after 4 h growth in SDG with or without 10% human serum in biological
triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the relative gene
expression of ALS3. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C)
and the housekeeping gene ACT1. Asterisks mark signicant dierences of hyperactive
Ahr1 mutants compared to the respective parental strain (*p ≤0.05, two tailed, unpaired
student's t-test).
3.4.4. Hyperactive Ahr1 induces Als3 localization on cell surface independent of Cph1 and
Efg1
A hyperactive Ahr1 was able to signicantly increase ALS3 expression in the wild type and in the
cph1∆/efg1∆ double mutant (cf. Fig. 12). To analyze whether this increased ALS3 expression
correlated with an increase in Als3 localization on the cell walls, an Als3 antibody was employed
to stain wild type and the cph1∆/efg1∆ mutants with and without hyperactive Ahr1 after 6 h
growth in yeast or hyphae-inducing medium (strain no. 1, 177, 104 and 157, Tab. 1). Additionally,
cells were stained with calcouor white to visualize the cell walls. Fig. 14 shows that Als3 could
already be located on wild type laments under yeast growth conditions if a hyperactive Ahr1 was
present. In contrast to this, the wild type without hyperactive Ahr1 only formed yeast cells, which
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did not show an Als3 signal under these conditions (Fig. 14). After serum-induction, the wild
type hyphae showed an Als3 signal on the hyphal surfaces which increased towards the hyphal
tip. A hyperactive Ahr1 induced clustering of wild type hyphae with the hyphae originating
in the middle and elongating towards the outside. The Als3 signal of these cells also increased
towards the hyphae tips and was overall a little more intense compared to the wild type without
hyperactive Ahr1 (Fig. 14). In the cph1∆/efg1∆ mutant with a hyperactive Ahr1, Als3 could
Fig. 14: Hyperactive Ahr1 induces Als3 localization on cell surface independent of
Cph1 and Efg1.
The wild type and the cph1∆/efg1∆ mutants with and without hyperactive Ahr1 were
grown for 6 h in SDG with or without 10% human serum at 37°C on µDishes. Subse-
quently, cells were stained with serum raised against Als3 (secondary antibody: goat-
anti-Rabbit-488-IgG (red)), xed with Histox and stained with calcouor white (blue).
An overlay of the DAPI and the A488 channel is depicted. Bar= 20 µm.
be localized on some elongated cells and pseudohyphae already under yeast growth conditions
(Fig. 14). After serum-induction this mutant formed pseudohyphae. They showed an Als3 signal
that increased towards the tips. The respective cph1∆/efg1∆ mutant without hyperactive Ahr1
was only able to form yeast cells under these conditions. Some of these cells showed a weak Als3
signal. This demonstrated that a hyperactive Ahr1 was not only able to increase ALS3 expression
independent of Cph1 and Efg1 but it also led to increased localization of the Als3 protein on the
cell surface of elongated cells, pseudohyphae and true hyphae.
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3.5. ChIP-Seq analyses of hyperactive Ahr1
3.5.1. Hyperactive Ahr1 binds upstream of ECE1, ALS3 and other core lamentation
response genes
The hyperactive Ahr1 had an inuence on the expression of ECE1, ALS3 and some other CFR
genes (cf. Fig. 5 and 12). ChIP-seq experiments were performed to analyze a possible direct
binding of the hyperactive Ahr1 upstream of CFR genes. Therefore the wild type with hyperactive
Ahr1 with and without HA3-tag (strain no. 177 and 427, Tab. 1) were grown for 6 h in SDG
at 37°C prior to ChIP-Seq analyses. Fig. 15 depicts the ORFs of ECE1 and ALS3 (blue), the
corresponding coordinates in the genome of the SC5314 wild type and the mapped ChIP-Seq
reads (red). In the 5' upstream untranslated region of each gene multiple peaks, which represent
binding sites, could be seen. This indicates that the hyperactive Ahr1 bound to multiple regions
upstream of the genes.
Fig. 15: Hyperactive Ahr1 binds to 5' intergenic regions of ECE1 and ALS3.
ChIP-seq reads (red) mapped to the the genome of the SC5314 wild type. The ORFs
of ECE1 and ALS3 are shown in blue. Images were created in the Integrated Genome
Browser (IGB).
A similar pattern could be observed for the CFR genes HWP1, IHD1 and HGT2. Fig. 16 shows
that in each gene's 5' intergenic region the mapped reads resulted in multiple peaks. For DCK1
and RBT1, one peak upstream of each ORF was identied (Fig. 16). However, these peaks
were not as as large as the peaks for ECE1, ALS3, HWP1, IHD1 and HGT2 (Fig. 15 and 16).
Upstream of orf19.2457 no peak could be identied, as depicted in Fig. 16.
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Fig. 16: Hyperactive Ahr1 binds to 5' intergenic regions of HWP1, IHD1, HGT2,
RBT1 and DCK1 but not orf19.2457.
ChIP-seq reads (red) mapped to the the genome of the SC5314 wild type. The open
reading frames of HWP1, IHD1, HGT2, RBT1, DCK1 and orf19.2457 are shown in
blue. Images were created in IGB.
3.5.2. Hyperactive Ahr1 binds upstream of and activates the expression of hyphal
regulators
The ChIP-Seq data was used to search for other interesting targets of the hyperactive Ahr1.
The analyses revealed that the hyperactive Ahr1 bound to 5' intergenic regions of several known
regulators of hyphal growth. Since binding does not always result in positive or negative regula-
tion, RT-qPCR analyses were performed to complement the ChIP-Seq data. Therefore, RNA of
the wild type and a mutant with hyperactive Ahr1 in the wild type background was extracted
under non-inducing growth conditions (strain no. 1 and 177, Tab. 1). In Fig. 17 (left panel) you
can see the binding proles upstream of the ORFs of AHR1, BCR1, BRG1 and EED1. While
upstream of AHR1, BRG1 and EED1 several large peaks could be found, for BCR1 only smal-
ler peaks were identied. Fig. 17 (right panel) shows the relative expression of AHR1, BCR1,
BRG1 and EED1. In all cases, the expression was signicantly upregulated in the mutant with
hyperactive Ahr1. Since the AHR1-GAD was transformed into the ADH1 locus, it was not clear
if the binding of Ahr1 to its own promotor resulted in AHR1 upregulation.
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Fig. 17: Hyperactive Ahr1 regulates AHR1, BCR1, BRG1 and EED1 expression
Left panel: ChIP-seq reads (red) mapped to the the genome of the SC5314 wild type.
The open reading frames of AHR1, BCR1, BRG1 and EED1 are shown in blue. Images
were created in the IGB.
Right panel: Total RNA of wild type with and without hyperactive Ahr1 was isolated
after 4 h growth in SDG at 37°C in biological triplicates. 100 ng/µl of this RNA was
used for RT-qPCR to determine the relative gene expression of AHR1, BCR1, BRG1
and EED1. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C) and
the housekeeping gene ACT1. Asterisks mark signicant dierences of hyperactive Ahr1
mutants compared to the wild type (*p ≤0.05, two tailed, unpaired student's t-test).
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Fig. 18: Hyperactive Ahr1 regulates EFG1, HGC1, SFL2 but not NDT80 expression.
Left panel: ChIP-seq reads (red) mapped to the the genome of the SC5314 wild type.
The open reading frames of EFG1, HGC1, NDT80 and SFL2 are shown in blue. Images
were created in IGB.
Right panel: Total RNA of wild type with and without hyperactive Ahr1 was isolated
after 4 h growth in SDG at 37°C in biological triplicates. 100 ng/µl of this RNA was
used for RT-qPCR to determine the relative gene expression of EFG1, HGC1, NDT80
and SFL2. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C) and
the housekeeping gene ACT1. Asterisks mark signicant dierences of hyperactive Ahr1
mutants compared to the wild type (*p ≤0.05, two tailed, unpaired student's t-test).
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Fig. 19: Hyperactive Ahr1 regulates TCC1, TEC1 and UME6 expression
Left panel: ChIP-seq reads (red) mapped to the the genome of the SC5314 wild type.
The open reading frames of TCC1, TEC1 and UME6 are shown in blue. Images were
created in IGB.
Right panel: Total RNA of wild type with and without hyperactive Ahr1 was isolated
after 4 h growth in SDG at 37°C in biological triplicates. 100 ng/µl of this RNA was used
for RT-qPCR to determine the relative gene expression of TCC1, TEC1 and UME6. Data
was normalized to a control RNA (wild type, 6 h YPD, 37°C) and the housekeeping gene
ACT1. Asterisks mark signicant dierences of hyperactive Ahr1 mutants compared to
the wild type (*p ≤0.05, two tailed, unpaired student's t-test).
Fig. 18 (left panel) depicts the ChIP-Seq binding proles upstream of EFG1, HGC1, NDT80
and SFL2. Again the binding prole of the hyperactive Ahr1 varied from region to region. For
the upstream region of EFG1 several large peaks were identied. For HGC1 only one relatively
small peak approx. 6,000 bp upstream the start codon was found. Approx. 2,000 bp upstream of
the NDT80 ORF, one large peak was spotted. In the nearly 10,000 bp long 5' intergenic region of
SFL2 several peaks were identied. For EFG1, HGC1 and SFL2, expression in the mutant with
the hyperactive Ahr1 was signicantly upregulated in comparison to the wild type, as displayed
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in Fig. 18 (right panel). It also shows that NDT80 expression was not upregulated, even though
the hyperactive Ahr1 bound upstream of the NDT80 ORF. Since NDT80 shares the intergenic
region with another, so far uncharacterized gene (EMC9 ), it is also possible that the hyperactive
Ahr1 regulated the expression of this gene and not NDT80. Furthermore, the hyperactive Ahr1
bound to several positions upstream of TCC1, TEC1 and UME6, which is presented in Fig.
19 (left panel). The RT-qPCR data in Fig. 19 (right panel) shows that the binding resulted in
an signicant increase in TCC1, TEC1 and UME6 expression. Summarizing, the hyperactive
Ahr1 bound to several 5' intergenic regions of know regulators of hyphal growth. For AHR1,
BCR1, BRG1, EED1,EFG1, HGC1, SFL2, TCC1, TEC1 and UME6 this binding corresponded
to an upregulated expression of each regulator. It is of note that several hyphal regulators have
relatively large 5' intergenic regions encompassing up to 10,000 base pairs. RT-qPCR analyses
showed that binding several thousand base pairs upstream of the start codon still had an inuence
on expression levels.
3.5.3. The hyperactive Ahr1 binds upstream of genes encoding for other cell wall proteins,
hyphal regulators and virulence factors
Next to the already mentioned CFR genes and hyphal regulators, also other targets of the hy-
peractive Ahr1 could be identied through the ChIP-Seq data. Some interesting ndings will be
summarized here (detailed summary: Tab. 8 in Sec. VII).
The expression of several cell-wall proteins could potentially be inuenced by a hyperactive Ahr1.
Next to ALS3, also peaks upstream of the ORFs of ALS1 and ALS4 could be found. These mem-
bers of the Als family also encode cell-surface adhesins in the C. albicans hyphae (Hoyer et al.,
2008). Similarly, peaks upstream of the gene encoding Hyr1, a GPI-anchored hyphal cell wall
protein (Bailey et al., 1996) and Eap1, a GPI-anchored cell wall adhesin (Li and Palecek, 2003)
were identied.
The hyperactive Ahr1 could also play a role in stress response. It could be involved in the regu-
lation of CDR1 and MDR1 expression, genes encoding a multidrug transporter and a multidrug
eux pump. Peaks in front of both ORFs were found. The hyperactive Ahr1 bound upstream
of the SOD5 ORF. The gene SOD5 encodes superoxide dismutase 5, which is located on the
hyphal cell surface. Sods play an important role in the reduction of oxidative stress imposed on
the fungus by host immune cells (see Section 1.2.2.4).
Additionally, other important virulence factors could be inuenced by the hyperactive Ahr1.
Peaks were also identied in the 5' intergenic regions of genes encoding for the secreted aspartyl
proteinases Sap4, Sap5 and Sap6. These hydrolases are associated with hyphal cell walls. They
enable nutrient acquisition from host cells through tissue damage, thus enhancing virulence (cf.
Sec. 1.2.2.3).
It is known that Ahr1 plays a critical role in white-opaque-switching of C. albicans. It has alrea-
dy been shown that Ahr1 directly binds upstream of and regulates the expression of the other
regulators of the white-opaque switch EFG1, WOR1, WOR2, WOR3 and CZF1 (Hernday et al.,
2013). The ChIP-Seq experiments conducted in this study indicate that this binding pattern is
also true for the hyperactive Ahr1.
Additionally, peaks upstream of LMO1, a gene encoding a protein involved in invasive lamen-
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tous growth together with Dck1 and Rac1 (Hope et al., 2010), were found. Next to the already
mentioned regulation of the expression of the transcription factor S2, which is required for la-
mentous growth, also S1, a negative regulator of hyphal development (Cao et al., 2006) could be
a possible target of the hyperactive Ahr1. Several peaks lay upstream of the transcription factor's
ORF. Another transcription factor, that could be inuenced by the binding of the hyperactive
Ahr1 to it's 5' intergenic region is Flo8. It is required for hyphal formation as it regulates hyphal
gene expression (Cao et al., 2006).
Lastly, it should be mentioned that the hyperactive Ahr1 also bound upstream of genes encoding
for Stp2 and Rim101. Stp2 is a transcription factor that is required for the alkalinization of me-
dium (Vylkova et al., 2011). Rim101 drives hyphal formation under alkaline conditions (Bensen
et al., 2004).
A list of the genes mentioned in the last three sections and the corresponding properties of the
read peaks (e. g. exact location, height) and identied motifs can be found in Tab. 8 in Sec. VII.
3.5.4. The binding motif of the hyperactive Ahr1
Using the ChIP-Seq data and the MEME-ChIP tool (Machanick and Bailey, 2011) one highly
signicant, centrally enriched binding motif of the hyperactive Ahr1 was identied. This motif,
displayed in Fig. 20, correlates to an already published motif of Ahr1 (Hernday et al., 2013).
MochiView (Homann and Johnson, 2010) was used to visualize the motif in the genome with the
corresponding ChIP reads.
Fig. 20: Binding site motif of hyperactive Ahr1 identied using MEME-ChIP.
Distribution of adenine (A), cytosine (C), guanine (G) and thymine (T) bases in the
binding motif. The higher the corresponding letter, the more likely this base is present
on that position in the motif sequence.
Focussing on hypha-specic genes, it was found that several peaks contained one or more motifs.
Oftentimes, the position of the motif coincided with local maxima (peak summit) in the peaks.
An example for this can be seen in Fig. 21 which shows a screenshot of the ECE1 ORF and its
5' upstream region. The identied peak, the peak summit and the identied motifs with motif
scores are displayed here. The motif score (red) states how identical the identied binding motif
(Fig. 20) is with the corresponding motif found in the genome (lowest score is 0, highest score is
6.58). A sought out list of CFR genes, hypha-specic transcription factors, virulence genes, other
already mentioned genes (Sec. 3.5.3) and the corresponding motifs identied in their intergenic
regions can be found in Sec. VII (Tab. 8).
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Fig. 21: Identied binding motifs coincide with local peak summits in 5' intergenic
region of ECE1.
ECE1 ORF with corresponding ChIP-Seq reads, the identied peak with summit and
identied binding motifs including motif score. The dashed lines indicate that identied
motifs often coincide with local peak maxima. Image created with MochiView (v. 1.46,
Homann and Johnson (2010)).
3.6. The role of Mcm1 in the expression of ECE1 and other core lamentation
response genes
3.6.1. MCM1 overexpression induces expression of ECE1 in a partly Ahr1-dependent
manner
As established in this study, Ahr1 plays an important role in the in the high-level expression
of ECE1 and other core lamentation response genes. Further on, Askew et al. (2011) found
that Ahr1 serves as a cofactor of Mcm1 by binding to the promotors of adhesion genes and
recruiting Mcm1 to these binding sites. Subsequently, the Ahr1-Mcm1-complex was shown to
activate the expression of these genes (e. g. ALS1, ALS4, HWP1, EFG1, TEC1, Askew et al.
(2011)). Additionally, the transcription factor Mcm1 possesses three possible binding sites in the
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5' intergenic region of ECE1 (cf. sec. 3.1.1). Thus, the role of Mcm1 in the expression of ECE1
and other CFR genes was investigated. SinceMCM1 is an essential gene (Rottmann et al., 2003),
the inuence ofMCM1 deletion on ECE1 expression could not be investigated. Therefore,MCM1
overexpression mutants in the wild type background and in the ahr1∆ mutant were generated
by transforming the MCM1 gene into the ADH1 locus. Additionally, the ECE1 -promotor-driven
GFP reporter system was employed to visualize ECE1 expression (strain no. 127, 413,128 and
414, Tab. 1). In the wild type MCM1 overexpression induced cell elongation and a GFP signal
in some cells, already under yeast growth conditions (Fig. 22A). In the ahr1∆ mutant there
was neither a morphological change due to overexpression of MCM1 nor a visible GFP signal
under yeast growth conditions (Fig. 22A). After serum-induction MCM1 overexpression induced
a GFP signal in wild type hyphae, which was slightly more intense than in the corresponding
parental strain (Fig. 22A). While no GFP signal was observable in the ahr1∆ hyphae, MCM1
overexpression in the ahr1∆ mutant induced a faint GFP signal in hyphae (Fig. 22A). This data
correlated with RT-qPCR data, displayed in Fig. 22B (strain no. 1, 350, 271, 352, Tab. 1).
Fig. 22: MCM1 overexpression (MCM1OE) induces ECE1 expression in partly Ahr1-
dependent manner.
AMCM1overexpressing strains of the wild type and the ahr1∆ mutants with the ECE1 -
promotor driven GFP reporter system were grown for 4 h in SDG with or without
10% human serum prior to microscopy. DIC and GFP channel images were merged.
Bar=10 µm.
B Total RNA of the wild type and the ahr1∆ mutants with and without MCM1 over-
expression was isolated after 4 h growth in SDG with and without 10% human serum
in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the
relative gene expression of ECE1. Data was normalized to a control RNA (wild type, 6
h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dierences
of hyperactive Ahr1 mutants compared to the respective parental strain (*p ≤0.05, two
tailed, unpaired student's t-test).
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It showed a signicant increase in ECE1 expression in the wild type which overexpressed MCM1
compared to the parental wild type strain. An increased expression of ECE1 was also measured
in the ahr1∆ mutant in which MCM1 was overexpressed. However this increase was not as high
as in the wild type. It appears that in order to induce high-level ECE1 expression by MCM1
overexpression, Ahr1 (a known cofactor of Mcm1 (Askew et al., 2011)) needed to be present.
3.6.2. The induction of ECE1 expression via MCM1 overexpression relies on Tup1 and
partly on Cph1 and Efg1
To further analyse the role of Mcm1 in ECE1 regulation, the MCM1OE construct was transfor-
med into the tup1∆ and the cph1∆/efg1∆ mutants. Fig. 23A shows micrographs of the strains
taken after 4 h incubation in SDG with or without 10% human serum at 37°C (strain no. 1,
14, 104, 350, 439 and 462, Tab. 1). In the wild type background the overexpression of MCM1
already led to the formation of short hyphae under non-inducing conditions. The tup1∆ mutant
was hyperlamentous, already under non-inducing conditions. Overexpression of MCM1 did not
change its morphology (Fig. 23A). After 4 h growth in SDG medium, the cph1∆/efg1∆ mutants
with or without MCM1 overexpression did solely grow in yeast form.
Fig. 23: Induction of ECE1 expression via MCM1 overexpression (MCM1OE) partly
relies on Tup1, Cph1 and Efg1.
A MCM1 was transformed in the ADH1 locus of the wild type and the tup1∆ and the
cph1∆/efg1∆ mutants. Cells were grown for 4 h in SDG with or without 10% human
serum at 37°C prior to microscopy in the DIC channel. Bar=10 µm
B Total RNA of the wild type and the tup1∆ and the cph1∆/efg1∆ mutants with and
without MCM1 overexpression was isolated after 4 h growth in SDG with and without
10% human serum in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR
to determine the relative gene expression of ECE1. Data was normalized to a control
RNA (wild type, 6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark
signicant dierences of hyperactive Ahr1 mutants compared to the respective parental
strain (*p ≤0.05, two tailed, unpaired student's t-test).
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The addition of human serum led to the elongation of some cph1∆/efg1∆ mutant cells with
MCM1 overexpression, while the parental strain stayed in yeast form (Fig. 23A). Fig. 23B depicts
the relative ECE1 expression in the above mentioned strains under non-inducing (SDG) and
inducing (SDG + serum) conditions after 4 h growth at 37°C. While MCM1 overexpression
was able to signicantly increase ECE1 expression in the wild type and to a smaller amount
in the cph1∆/efg1∆ mutant, there was no measurable increase in the tup1∆ mutant under
non-inducing conditions (Fig. 23B). Under hyphae-inducing conditions, MCM1 overexpression
was able to signicantly increase ECE1 expression in the tup1∆ and the cph1∆/efg1∆ mutants.
However, ECE1 expression in these mutants could not reach the same level as in wild type hyphae,
suggesting that induction of high-level ECE1 expression viaMCM1 overexpression requires Tup1
or Cph1 and Efg1.
3.6.3. MCM1 overexpression induces the expression of other CFR genes
The overexpression of MCM1 led to an induction of ECE1 expression, already under yeast
growth conditions (cf. Fig. 22 and 23). This mechanism was partly dependent on Ahr1, a known
co-factor of Mcm1 (cf. Fig. 22). Additionally, the lack of the transcription regulators Tup1 and
Cph1 and Efg1 also had a negative inuence on the induction of ECE1 expression via MCM1
overexpression (cf. Fig. 23). It was already shown that hyperactivation of Ahr1 induces not only
the expression of ECE1 but also the expression of other CFR genes, such as ALS3, HWP1
and IHD1 without necessary cues for hyphal formation and independent of Cph1 and Efg1 (cf.
Fig. 12). Thus, it was tested whether the overexpression of MCM1 also had an inuence on the
expression of other CFR genes in the wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆
backgrounds (strain no. 1, 14, 104, 350, 439, 462, 271, 352, Tab. 1). The results of RT-qPCR
analyses are displayed in Fig. 24.
MCM1 overexpression was able to signicantly increase ALS3, IHD1 and HWP1 expression in
the wild type background after 4 h growth in SDG medium, but not after serum-induction (Fig.
24). In the ahr1∆ background, MCM1 overexpression did lead to no or only a slight increase
in the expression of these genes without reaching the level of wild type hyphae (Fig. 24). In the
tup1∆ mutant the expression of IHD1 and HWP1 was not increased due to an overexpression of
MCM1 under yeast growth conditions. Fig. 24 shows that ALS3 expression was increased in the
tup1∆ mutant with MCM1 overexpression, but was not able to reach wild type hyphae level.
After serum-induction, the expression of ALS3, IHD1 and HWP1 was either not or only slightly
increased in the tup1∆ mutant with MCM1 overexpression, without reaching wild type hyphae
levels. In the cph1∆/efg1∆ mutant MCM1 overexpression did induce a slight increase in IHD1
and no increase in ALS3 and HWP1 expression under the tested yeast growth conditions (Fig.
24). After serum-induction, MCM1 overexpression induced a signicant increase in ALS3, IHD1
and HWP1 expression in the cph1∆/efg1∆ background, which did not reach the level of wild
type hyphae. Fig. 24 shows that there was no clear pattern observable for MCM1 overexpression
induced expression of DCK1 and orf19.2457. Interestingly, the expression of HGT2 was much
higher in the tup1∆ and the cph1∆/efg1∆ mutants than in the wild type and the ahr1∆ mutant
under yeast growth conditions. This is especially interesting since it is a CFR gene and while
tup1∆ is a hyperlamentous mutant (cf. Fig.23), the cph1∆/efg1∆ mutant is locked in yeast
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form (cf. Fig. 23). Strikingly, HGT2 expression in the wild type and the ahr1∆ mutant was
signicantly downregulated due to MCM1 overexpression under hyphal growth conditions (Fig.
24).
Fig. 24: MCM1 overexpression induces the expression of some CFR genes but often-
times depends on Ahr1, Tup1 or Cph1/Efg1.
Total RNA of the wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants
with and without MCM1 overexpression was isolated after 4 h growth in SDG with and
without 10% human serum in biological triplicates. 100 ng/µl of this RNA was used
for RT-qPCR to determine the relative gene expression of ALS3, HWP1, IHD1, HGT2,
DCK1, RBT1 and orf19.2457. Data was normalized to a control RNA (wild type, 6 h
YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dierences of
MCM1 overexpression mutants compared to the respective parental strain (*p ≤0.05,
two tailed, unpaired student's t-test).
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As shown earlier in Fig. 12 hyperactive Ahr1 led to increased HGT2 expression in the wild
type under yeast growth conditions, it's expression was signicantly downregulated after serum-
induction. It appears that Mcm1 and its cofactor have a negative inuence on the expression of
HGT2 under serum conditions. In the tup1∆ mutant on the other hand, HGT2 expression was
signicantly increased due to MCM1 overexpression under hyphal growth conditions, as shown
in Fig. 24. Additionally, HGT2 expression in the tup1∆ mutant was higher under yeast growth
conditions than in hyphal growth conditions. MCM1 overexpression had no inuence on RBT1
expression in the cph1∆/efg1∆ mutant (Fig. 24). However, in the wild type and the ahr1∆
mutant it signicantly increased RBT1 expression under the tested yeast growth conditions.
Under hyphal growth conditions, MCM1 overexpression was also able to signicantly increase
RBT1 expression in the tup1∆ mutant. Summing up, MCM1 overexpression did not only have
an eect on ECE1 expression, but also on ALS3, HWP1, IHD1 and RBT1 expression. However,
this eect appeared to be only intermediate or non-existent in the ahr1∆, the tup1∆ and the
cph1∆/efg1∆ mutants.
3.6.4. MCM1 overexpression induces Als3 localization on cell surface
As already described, MCM1 overexpression increased ALS3 expression in the wild type. This
phenomenon was decreased in mutants lacking AHR1, TUP1 and CPH1/EFG1. To examine if
this correlated with Als3 localization on the surface, the strains were grown for 6 h under yeast
and hyphal growth conditions (strain no. 1, 14, 104, 350, 439, 462, 271, 352, Tab. 1). Subsequently,
Als3 staining was performed as described earlier. Fig. 25 illustrates these Als3-stained cells.
Under yeast growth conditions, only MCM1 overexpression in the wild type background led to
a weak Als3 signal in some cells. Interestingly, tup1∆ with MCM1 overexpression did not show
Fig. 25: MCM1 overexpression induces Als3 localization on cell surface.
The wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants with and
without MCM1 overexpression were grown for 6 h in SDG with or without 10% human
serum at 37°C on µDishes. Subsequently, cells were stained with an anti Als3-antibody
(secondary antibody: goat-anti-Rabbit-488-IgG (red)), xed with Histox and stained




any Als3 signal (Fig. 25), even though ALS3 expression in this mutant was higher than in the
wild type with MCM1 overexpression (cf. Fig.24). After serum-induction, MCM1 overexpression
led to a brighter Als3 signal in the wild type background compared to the respective parental
strain, as depicted in Fig. 25. The Als3 signal for the ahr1∆ mutants with or without MCM1
overexpression only showed an Als3 signal on the very tip of some hyphal cells. Also in the
tup1∆ mutant with and without MCM1 overexpression, only the very tips of the cell laments
showed an Als3 signal (Fig. 25). As already shown before, the cph1∆/efg1∆ mutant stayed in
yeast form and did not show any Als3 signal (cf. Fig. 14). When MCM1 was overexpressed, the
cph1∆/efg1∆ cells elongated and an Als3 signal was visible on the tips of some cells after serum
induction.
3.7. The inuence of a mutated SSN3 allele on the expression of ECE1, ALS3
and other CFR genes
3.7.1. Mutated SSN3 allele induces ECE1 expression
In this study, a hyperactive Ahr1 as well as the overexpression of MCM1 were able to induce
lamentation and expression of ECE1 and ALS3 in the normally yeast-locked cph1∆/efg1∆
mutant (cf. Fig. 5 and 23). A similar phenomenon has been observed in a study from 2014.
A single nucleotide polymorphism (SNP) in the SSN3 gene of the yeast-locked cph1∆/efg1∆
mutant was shown to rescue the double mutant's lamentation defect, along with inducing the
expression of (among others) ECE1 and ALS3 (Wartenberg et al., 2014). To investigate a possible
link between the mutation in SSN3 and the earlier identied roles of Ahr1 and Tup1 on the
expression of ECE1 and other CFR genes, a mutated SSN3 (SSN3m) was transformed into the
ADH1 locus of the wild type. Additionally, it was transformed into the ahr1∆ and the tup1∆
background to analyze whether the lack of any of these transcriptional regulators had an impact
on the inuence of SSN3m. Furthermore, SSN3m was transformed into the cph1∆/efg1∆mutant.
For microscopy, ECE1 promotor driven GFP strains were used to visualize ECE1 expression in
wild type and the ahr1∆ and tup1∆ mutants (strain no. 127, 128, 132, 364, 218, 267, 104 and
109, Tab. 1). Fig. 26A shows micrographs of the strains taken after 4 h growth in SDG with or
without 10% human serum at 37°C. Mutation of SSN3 already induced a GFP signal in some cells
in the wild type background under yeast growth conditions (Fig. 26A). The same was true for the
ahr1∆ mutant, although the GFP signal was not as strong as in the SSN3mmutant in the wild
type background (Fig. 26A). A transformation of SSN3m into the ADH1 locus of tup1∆, resulted
in a bright GFP uorescence under yeast and hyphal growth conditions, shown in Fig. 26A. The
mutation of SSN3 did not have an inuence on yeast growth of the cph1∆/efg1∆ mutant under
non-inducing conditions. Under hyphal growth conditions, wild type hyphae showed a bright GFP
uorescence, which was a little brighter in the SSN3m strain (Fig. 26A). The SSN3 mutation in
the ahr1∆ background resulted in a bright GFP uorescence of some, but not all hyphae. As
already known (Wartenberg et al., 2014), SSN3m led to hyphal formation of in the cph1∆/efg1∆
background after serum-induction. Again, due to a lack of selection markers the GFP reporter
system could not be transformed into the cph1∆/efg1∆ mutant.
For RT-qPCR analyses, strains without GFP reporter system were analysed (strain no. 1 , 271,
14, 104, 106, 109, 460 and 461, Tab. 1). Fig. 26B illustrates the relative expression of ECE1
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after 4 h growth in SDG with or without 10% human serum in wild type and the ahr1∆, the
tup1∆ and the cph1∆/efg1∆mutants with and without mutated SSN3. The SSN3m signicantly
increased ECE1 expression in the wild type and all mutants under both growth conditions, which
correlated to the microscopic ndings in Fig. 26A. Under hyphal growth conditions, this increase
in the tup1∆ background was quite small and, in contrast to the expression in the ahr1∆ and
the cph1∆/efg1∆ mutants with mutated SSN3, not able to reach wild-type hyphae level. This
Fig. 26: Mutated SSN3 allele (SSN3m) induces ECE1 expression in the wild type
and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants.
A The wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants with and
without SSN3m transformed into the ADH1 locus. For wild type, ahr1∆ and tup1∆
mutants, the ECE1 promotor driven GFP reporter system could additionally be em-
ployed. Micrographs were taken after 4 h growth in SDG with or without 10% human
serum at 37°C. DIC and GFP channel images were merged. Bar=10 µm.
B Total RNA of the wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆mutants
with and withoutSSN3m was isolated after 4 h growth in SDG with and without 10%
human serum in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR to
determine the relative gene expression of ECE1. Data was normalized to a control RNA
(wild type, 6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant
dierences of SSN3m mutants compared to the respective parental strain (*p ≤0.05, two
tailed, unpaired student's t-test).
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shows that SSN3m was able to induce ECE1 expression not only independent of Cph1 and Efg1
and cues for hyphal formation (which was already known), but also independent of Ahr1 and
partly independent of Tup1.
3.7.2. Mutated SSN3 allele induces ALS3 expression and Als3 localization on cell surfaces
Subsequently, the role of SSN3m in ALS3 expression and Als3 localization on the cell surfaces
was investigated. The RT-qPCR analyses, displayed in Fig. 27 A, show relative ALS3 expression
in the wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants with and without
SSN3m after 4 h growth in SDG with or without 10% human serum (strain no. 1 , 271, 14,
104, 106, 109, 460 and 461, Tab. 1). The mutation of SSN3 resulted in signicantly increased
levels of ALS3 expression in the wild type, the ahr1∆ and the tup1∆ backgrounds compared to
the respective parenteral strains, already under non-inducing conditions. However, in the ahr1∆
background this increase was only intermediate in yeast growth conditions. For the cph1∆/efg1∆
double mutant a mutated SSN3 allel did not increase the ALS3 expression under these conditions.
After 4 h serum induction, a signicant increase in ALS3 expression was visible for the wild type
and all mutants (Fig. 27A). Fig. 27 B shows Als3 straining performed on the strains mentioned
above. In the wild type background SSN3 mutation led to the formation of hyphae displaying
an Als3 signal already under yeast growth conditions (Fig. 27B). While the ahr1∆ mutant only
rarely formed laments under these conditions, the ahr1∆ mutant with SSN3m formed laments,
showing a faint Als3 signal, more frequently. Under yeast growth conditions, the tup1∆ mutant
did not show an Als3 signal. However, SSN3m induced an Als3 signal of the lament tips of the
tup1∆ mutant under these conditions (Fig. 27B). There was no visible dierence between the
cph1∆/efg1∆ mutants with or without SSN3m in terms of Als3 localization under yeast growth
conditions. Both mutants remained in yeast form without a notable Als3 signal, as depicted in
Fig. 27B.
Unfortunately, due to a change in the serum-batch the induction of hyphal growth and Als3
localization was weaker in this assay compared to previous Als3 staining experiments. After
5 h serum induction, an Als3 signal which increased towards the hyphal tips could be seen in
the wild type. Due to the mutation of the SSN3 allele, this signal could be slightly increased
(Fig. 27B). While the ahr1∆ hyphae did only rarely display an Als3 signal, SSN3m lead to an
induction of Als3 localization on the laments' surfaces, which increased towards the tips (Fig.
27A). The Als3 signal of the tup1∆ mutant concentrated on the very tips of the laments under
hyphal growth conditions. This signal could be increased due to SSN3m, as shown in Fig. 27A.
As already mentioned earlier (cf Fig. 25), the cph1∆/efg1∆ double mutant remained in yeast
form after serum-induction, which did not show an Als3 signal. The mutation of the SSN3 allele
was able to rescue the mutants ability to form hyphae under serum-inducing conditions. These
hyphae showed an Als3 signal similar to the wild type hyphae (Fig. 27B). Taken together, the
SNP mutation of SSN3 was able to induce ALS3 expression and localization on the cell walls
independent of Ahr1, Tup1 and Cph1/Efg1.
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Fig. 27: Mutated SSN3 allele (SSN3m) induces ALS3 expression and Als3 localizati-
on on cell surface.
A Total RNA of the wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆mutants
with and without SSN3m was isolated after 4 h growth in SDG with and without 10%
human serum in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR to
determine the relative gene expression of ALS3. Data was normalized to a control RNA
(wild type, 6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant
dierences of SSN3m mutants compared to the respective parental strain (*p ≤0.05, two
tailed, unpaired student's t-test).
B The wild type and the ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants with and
without SSN3m were grown for 5 h in SDG with or without 10% human serum at 37°C
on µDishes. Subsequently, cells were stained with an anti Als3-antibody (secondary an-
tibody: goat-anti-Rabbit-488-IgG (red)), xed with Histox and stained with calcouor
white (blue). An overlay of the DAPI and the A488 channel is depicted. Bar=20 µm.
3.7.3. Mutated SSN3 allele induces the expression of other CFR genes
The inuence of the mutated SSN3 (SSN3m) allele on the expression of the other CFR genes was
assessed via RT-qPCR. Therefore RNA from the wild type and the ahr1∆, the cph1∆/efg1∆
and the tup1∆ mutants with or without SSN3m was extracted after 4 h growth in SDG with or
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without 10% human serum (strain no. 1 , 271, 14, 104, 106, 109, 460 and 461, Tab. 1). Fig. 28
displays the determined relative expressions of IHD1, HWP1, HGT2, DCK1, orf19.2457 and
RBT1 of these strains. The mutation of SSN3 was able to signicantly increase the expression of
IHD1 in the wild type and the ahr1∆ background under non-inducing and inducing conditions
compared to the respective parental strains (Fig. 28).
Fig. 28: Mutated SSN3 allele (SSN3m) inuences the expression of CFR genes.
Total RNA of the wild type and ahr1∆, the tup1∆ and the cph1∆/efg1∆ mutants
with and without SSN3m was isolated after 4 h growth in SDG with and without 10%
human serum in biological triplicates. 100 ng/µl of this RNA was used for RT-qPCR
to determine the relative gene expression of IHD1, HWP1, HGT2, DCK1, orf19.2457
and RBT1. Data was normalized to a control RNA (wild type, 6 h YPD, 37°C) and
the housekeeping gene ACT1. Asterisks mark signicant dierences of SSN3m mutants




Additionally, a signicant increase in IHD1 in the cph1∆/efg1∆ mutant with SSN3m after
serum-induction could be observed, as depicted in Fig. 28. Under yeast growth conditions, a
signicant increase in HWP1 expression due to SSN3m could be noted in the wild type back-
ground and the ahr1∆ and the tup1∆ mutants compared to their parental strains. After serum-
induction, this was true for the wild type background, and the ahr1∆ and the cph1∆/efg1∆
mutants. Fig. 28 shows that HGT2 expression was signicantly reduced in the cph1∆/efg1∆
mutant with SSN3m compared to its parental strain under non-inducing conditions. However,
under hyphae-inducing conditions, it was signicantly increased. For the other strains, no signi-
cant dierences in expression could be noted (Figure 28). While there were no signicant changes
in DCK1 expression noted under non-inducing conditions, a mutated SSN3 allele was able to
signicantly increase DCK1 expression in the wild type and the ahr1∆ and the cph1∆/efg1∆
mutants under hyphae-inducing conditions. Interestingly, as shown in Fig. 28, SSN3m in the
tup1∆ mutant led to a signicant decrease in DCK1 expression after serum-induction. The ex-
pression of orf19.2457 was signicantly increased in the ahr1∆ mutant with SSN3m compared
to its parental strain under non-inducing conditions. Under hyphae-inducing conditions SSN3m
resulted in a signicant upregulation of orf19.2457 expression in the wild type background and
the ahr1∆ and the cph1∆/efg1∆ mutants, as depicted in Figure 28. While SSN3m in the wild
type background and the ahr1∆ mutant led to a signicant increase in RBT1 expression under
non-inducing conditions, a signicant decrease under hyphae-inducing conditions of these strains
could be observed compared to their respective parental strains (Fig. 28). Additionally, RBT1
expression was also signicantly decreased in the tup1∆ mutant with SSN3m, while a signicant
increase in RBT1 expression in the cph1∆/efg1∆ mutant with SSN3m could be observed (Fig.
28).
3.7.4. Deletion of SSN3 induces expression of ECE1 and ALS3 and other CFR genes
A mutated allele SSN3 led to the upregulation of ECE1 and ALS3 in the wild type background,
which was largely independent of Ahr1, Tup1 and Cph1/Efg1 (Fig. 26 and 27). Subsequently, it
is possible that the deletion of SSN3 has a negative eect on the expression of these genes and
that a hyperactive Ahr1 may be able to rescue this defect.
To test for ECE1 expression, the GFP reporter system was transformed into the ssn3∆ mutants
with and without hyperactive Ahr1 (strain no. 522, 552, Tab. 1). Subsequently, strains were
grown in SDG with and without 10% human serum for 4 h and microscopic images were taken.
Interestingly, both mutants formed hyphae already under yeast growth conditions and exhibited
a bright GFP signal, which was a little brighter in the mutant with the hyperactive Ahr1 (Fig.
29A). Fig. 32 in Sec. VII shows that this was not the case in other yeast-inducing conditions
such as growth at 37°C in YPD and M199 (pH 4) or at 30°C in SDG, where the wild type
and the ssn3∆ mutant formed non-uorescing yeast cells. For RT-qPCR conrmation, wild type
and the ssn3∆ strains were grown under the same conditions mentioned above and RNA was
isolated (strain no. 1, 250, 279, Tab. 1). Relative expression of ECE1 conrmed the microscopic
data. Compared to the wild type, ECE1 expression was signicantly increased in ssn3∆ with
and without hyperactive Ahr1 under yeast growth conditions (Fig. 29A). Similar results were
obtained concerning the expression of ALS3, depicted in Fig. 29B.
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Fig. 29: Deletion of SSN3 induces expression of ECE1 and ALS3 and Als3 localica-
tion on lament surface.
Total RNA of the wild type and the ssn3∆ mutants with and without hyperactive Ahr1
was isolated after 4 h growth in SDG with and without 10% human serum in biological
triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the relative gene
expression of ECE1 (A) and ALS3 (B). Data was normalized to a control RNA (wild
type, 6 h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dif-
ferences between strains (*p ≤0.05, two tailed, unpaired student's t-test).
A right panel: The ECE1 promotor driven GFP reporter system was transformed into
the ssn3∆ mutants with and without hyperactive Ahr1. Micrographs of these strains
were taken after 4 h growth in SDG with or without 10% human serum at 37°C. Depic-
ted are overlays of the DIC and GFp channels. Bar=10µm.
B left panel: The ssn3∆ mutant with and without hyperactive Ahr1 were grown for
5 h in SDG with or without 10% human serum at 37°C on µDishes. Subsequently, cells
were stained with an anti Als3-antibody (secondary antibody: goat-anti-Rabbit-488-IgG
(red)), xed with Histox and stained with calcouor white (blue). An overlay of the
DAPI and the A488 channel is depicted. Bar= 20 µm.
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Fig. 30: Deletion of SSN3 induces expression of HWP1 and IHD1.
Total RNA of the wild type and the ssn3∆ mutants with and without hyperactive Ahr1
was isolated after 4 h growth in SDG with and without 10% human serum in biological
triplicates. 100 ng/µl of this RNA was used for RT-qPCR to determine the relative gene
expression of IHD1 and HWP1. Data was normalized to a control RNA (wild type, 6
h YPD, 37°C) and the housekeeping gene ACT1. Asterisks mark signicant dierences
(*p ≤0.05, two tailed, unpaired student's t-test).
To ascertain whether this upregulation of ALS3 correlated to increased Als3 localization on
C. albicans hyphae, Als3 staining with the ssn3∆ mutant with or without hyperactive Ahr1 was
performed (strain no. 250, 279, Tab. 1). Under yeast growth conditions, only little Als3 could
be spotted in the ssn3∆ mutant, while the mutant with the hyperactive Ahr1 showed an Als3
signal along the hyphal tips (Fig. 29B). Unfortunately, a change in the serum-batch resulted in
a reduction of hyphal formation, which had an inuence on the Als3 localization of the wild
type. This should be kept in mind when comparing the images shown in this section with earlier
images of Als3 staining. After serum induction, Als3 on ssn3∆ mutant cells oncentrated on the
very tips of the hyphae. This was similar for the ssn3∆ mutant with a hyperactive Ahr1, where
the Als3 signal was generally stronger than in the parental strain, as displayed in Fig. 29.
Since, SSN3 deletion had an eect on ECE1 and ALS3 expression, also the relative expression of
HWP1 and IHD1 was analyzed. Through the deletion of SSN3 the relative expressions of HWP1
and IHD1 were signicantly increased under yeast growth conditions (Fig. 30). This increase was
a little higher in the mutant with a hyperactive Ahr1. The inuence of SSN3 deletion on the




The ability of C. albicans to undergo reversible yeast-to-hyphae transition is crucial for its vi-
rulence. This morphological change, induced by various environmental stimuli, correlates with
the upregulation of dierent hypha-specic genes. One of the most transcribed genes in hyphae
is ECE1, which is not essential for hyphae formation but for the virulence of the fungus (Birse
et al., 1993; Moyes et al., 2016). Once translated, the Ece1 protein is further processed by the
protein kinases Kex1 and Kex2 into eight peptides which are secreted from hyphae (Bader et al.,
2008; Moyes et al., 2016). One of these peptides, Candidalysin, is a toxin and crucial for the
induction of host cell cytolyis (Moyes et al., 2016; Richardson et al., 2018b; Swidergall et al.,
2019). Homologs of Candidalysin were so far only identied in the closest relatives of C. albicans,
C. dubliniensis and C. tropicalis (Richardson et al., 2019). The virulence of C. albicans and
probably also the other Candida species expressing ECE1 homologs seems to be strongly de-
pendent on the ability to form Candidalysin. Due to its importance for fungal virulence, insights
into the regulation of ECE1 can contribute to the comprehension of the fungal pathogenicity
mechanisms.
4.1. The transcription factor Ahr1 is required for high-level expression of ECE1
and Candidalysin secretion
So far, several transcriptional regulators were shown to play a role in ECE1 expression in C.
albicans. However, deletion mutants of these regulators usually exhibited hyphal growth defects,
leading to the question if ECE1 transcription is low due to the absent binding of transcripti-
on factors or due to the defects in hyphal formation. For example, deletion of EFG1 leads to a
yeast-locked phenotype with low ECE1 expression levels under hyphal growth conditions (Braun
and Johnson, 2000). Other transcription factors with a positive inuence on ECE1 expression
are Ume6 and Ndt80 (Zeidler et al., 2008; Carlisle et al., 2009; Sellam et al., 2010). But mu-
tants lacking these regulators have defects in hyphal maintenance or growth (Banerjee et al.,
2008; Sellam et al., 2010). In yeast cells, expression of ECE1, ALS3 and HWP1 is repressed by
Nrg1, which, together with its co-factor Tup1, binds to the promotors of hypha-specic genes
(Garcia-Sanchez et al., 2005; Murad et al., 2001a,b). Upon hyphal induction, Nrg1 is quickly
downregulated and degraded (Martin et al., 2013; Lu et al., 2011). During hyphal elongation,
Brg1 recruits Hda1 to promotors of these hypha-specic genes (Lu et al., 2012). This causes
nucleosome repositioning which leads to a Brg1-mediated suppression of Nrg1 binding (Lu et al.,
2012). Consequently, deletion of BRG1 results in defective hyphal elongation (Lu et al., 2012).
In contrast, the expression of ECE1 is derepressed in the pseudohyphal tup1∆ mutant, but still
lower than in wild type hyphae (Braun and Johnson, 2000; Braun et al., 2001). All of the above
mentioned deletion mutants are reduced in their virulence (Lo et al., 1997; Banerjee et al., 2008;
Yang et al., 2012; Sellam et al., 2010; Braun et al., 2000; Allert et al., 2018). Aside the morpholo-
gical defects, a low or only intermediate ECE1 expression and consequently lower Candidalysin
production could be an explanation for this. Due to this, this study focused on determining which
transcription factors regulate ECE1 expression in the hyphal morphology of C. albicans.
Findings from this study concur that during serum induction at 37°C (one of the strongest in-
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ducers for hyphal formation), a reduction of ECE1 expression through the deletion of target
transcription factors usually coincided with a hyphal growth defect. The sole exemption was a
mutant lacking the AHR1 gene. It was the only mutant in the screen able to form wild type-like
hyphae, while expressing signicantly less ECE1 compared to wild type hyphae. Furthermore,
the ahr1∆ mutant was already shown to exhibit reduced virulence in systemic infection in mi-
ce (Askew et al., 2011) and in an intestinal epithelial infection model (Allert et al., 2018). In
addition, it was already described that the mutant has a decreased ability to lyse macrophages
and to induce IL-1β secretion of macrophages, despite forming normal hyphae (Wellington et al.,
2014, 2012). Similar characteristics were also observed in C. albicans mutants lacking the gene
encoding for Candidalysin (Moyes et al., 2016; Swidergall et al., 2019; Verma et al., 2017; Kasper
et al., 2018). In the current study, the only intermediate ECE1 expression of the ahr1∆ hyphae
correlated to a reduced secretion of Candidalysin. This might be an explanation for the low
virulence of the ahr1∆ mutant.
4.2. A hyperactive Ahr1 induces high-level ECE1 expression independent of
Cph1 and Efg1
The integration of a hyperactive AHR1 allele into the wild type, led to a signicant increase of
ECE1 expression even under yeast growth conditions. However, this upregulation did not result
in enhanced Candidalysin secretion, indicating that hyphal morphology and associated processes
are essential for the secretion of the peptide. The mechanistic reason remained unresolved within
this study. It might be that the alterations in the fungal cell during the yeast to hyphae transiti-
on are required for the eective secretion of Candidalysin. It is also possible that the processing
of the Ece1 propetide requires so far unknown hyphae-associated steps. Another possibility is
that the procession of Ece1 by Kex1 and Kex2 is defective in the yeast cell morphology. Kex2
is a membrane bound serine protease which processes proteins for secretion in the golgi. For its
activation, the N-terminus of the enzyme undergoes several posttranslational processing steps.
During these steps the inactive endoplasmatic-reticulum-bound Kex2 matures to the active enzy-
me which relocates to the golgi apparatus (for review on Kex2 see Rockwell and Thorner (2004)).
It is possible that in C. albicans yeast cells the maturation of Kex2 or its ability to recognize
Ece1 as target protein could be inhibited. To analyze this, intracellular levels of Candidalysin
and the other Ece1 peptides in mutants with a hyperactive Ahr1 under yeast growth conditions
should be measured.
A striking observation for the hyperactive Ahr1 was the upregulation of ECE1 in the non-
lamentous cph1∆/efg1∆ double mutant even under yeast growth conditions. First, this under-
lines the central role of Ahr1 for the expression of ECE1, second it reveals a so far unknown
possibility to bypass the absence of Cph1 and Efg1 and third, it conrmed the observation that
upregulation of the ECE1 gene alone does not necessarily lead to the secretion of Candidalysin.
Like for the wild type background, it was observed that the double mutant with the hyperactive
Ahr1 was not secreting Candidalysin under yeast growth conditions, even though ECE1 expres-
sion was similar to that of wild type hyphae. Under hyphal growth conditions, the secretion
of the peptide was comparable to wild type hyphae, although the cph1∆/efg1∆ mutant with
hyperactive Ahr1 did not grow strictly in hyphae, but more in a mixture of yeast cells, pseu-
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dohyphae and hyphae. Nevertheless, the cytotoxicity towards epithelial cells stayed unchanged.
According to Moyes et al. (2016), invading C. albicans hyphae secret Candidalysin into invasion
pockets in epithelial cells where it accumulates. Once a lytic concentration of Candidalysin is
reached, membranes are damaged and LDH is released. These invasion pockets are stretching the
epithelial membranes and probably facilitate the intercalation and damage induction of Candi-
dalysin. Thus, non-hyphae-forming mutants like the cph1∆/efg1∆ double mutant might exhibit
a reduced virulence even though Candidalysin secretion is wild type like. Moyes et al. (2016)
also showed, that the Ece1-III peptide alone is already sucient to induce damage, which speaks
against the prerequisite of hyphae and invasion pocket formation. However, they employed 70
µM of the peptide, which may be much higher than the actual physiological concentration that
can be reached during interaction between C. albicans and mammalian cells.
The data presented here show that the action of the hyperactive Ahr1 concerning ECE1 expres-
sion is independent from Cph1 and Efg1 and thus the MAPK and the cAMP-PKA pathways but
subsequent damage induction via Candidalysin relies on hyphae formation.
4.3. A hyperactive Ahr1 binds upstream of ECE1, ALS3 and other core
lamentation response genes and activates their expression
A hyperactive Ahr1 induces the expression of ECE1. Similar results were found for the core
lamentation response genes ALS3, HWP1 and IHD1. All three of them were only expressed at
intermediate levels in the ahr1∆ mutant and upregulated after the integration of a hyperactive
AHR1 allele into the wild type and the cph1∆/efg1∆ background. ALS3 is encoding for a
multifunctional protein which is involved in adhesion to and invasion of human host cells (Hoyer
et al., 2008; Phan et al., 2007). It is also crucial for fungal iron acquisition in infected host
cells, as it mediates the binding of ferritin of C. albicans (Almeida et al., 2008). Intermediate
ALS3 expression was not sucient for the localization of the Als3 protein on ahr1∆ hyphae.
In contrast, a hyperactive Ahr1 led to an increased expression of this gene in the wild type
background as well as in the cph1∆/efg1∆ mutant. Consequently, it could be shown that the
localization of Als3 increased due these increased transcription levels. As there are no functional
assays for Hwp1 and Ihd1, it can only be speculated that the low expression of these genes in
the ahr1∆ mutant results in decreased protein function. In the future, the presence of these
proteins in the ahr1∆ mutant could be investigated. The expression data for ECE1 and ALS3
raised the question if Ahr1 regulates these genes directly or indirectly. To answer this, ChIP-Seq
analyses with a hyperactive HA3-tagged Ahr1 were performed. These experiments were conducted
under yeast growth conditions and indeed proved a physical binding of hyperactive Ahr1 to the
promoters of ALS3, ECE1, HWP1 and IHD1. For future experiments, it should be kept in mind
that the hyperactive Ahr1 is an articial system and that clues about the possible role in gene
regulation gained via ChIP-Seq and other experiments, may not coincide with the actual behavior
of the transcription factor in vivo. However, hyperactivation of a zinc-cluster transcription factor
has been shown to be a good tool for identifying regulators of virulence-associated features in
the past (Schillig and Morschhäuser, 2013). Especially, since the deletion of genes encoding for
transcription factors does not always lead to a certain phenotype that gives hints about the role
of the gene. For more accurate results, tagging of Ahr1 and possible interactions partners should
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be performed in the native loci. The ChIP-Seq data was used to identify the binding motif of the
hyperactive Ahr1. This motif was identical to an already published one, where Ahr1 was myc-
tagged in its native locus (Hernday et al., 2013), which speaks for the validity of this study's
results gathered with the hyperactive Ahr1.
Within the 5' intergenic region of ECE1 three main binding sites of the hyperactive Ahr1 at
positions 2721, 2012, and 996 bp upstream of the start codon were identied. Two of these binding
sites at positions 996 and 2012 bp upstream the start codon are situated in the Crick strand and
therefore in the same orientation as the ECE1 ORF itself. Due to this, the gathered results are
a valuable data set to further study the inuence of Ahr1 on the expression of ECE1. To assess
the necessity of these sites for Ahr1 binding, each binding site or a combination of binding sites
could be deleted or changed by site-directed mutagenesis. A logical application tool would be
the established GFP reporter system as it provides a fast and uncomplicated visualization for
ECE1 expression. Alternatively, these binding sites could be deleted in their native locus, e. g.
by established CRISPR-Cas9 protocols (Nødvig et al., 2015). Afterwards, ECE1 expression and
(if desired) Candidalysin secretion could be examined. In addition, a ChIP PCR-based approach
could prove, if a binding of Ahr1 still occurs or not. It is also feasible that sequential binding to all
binding sites occurs. ChIP-PCR at dierent time points could clarify dynamic Ahr1 occupancy
at the ECE1 promotor.
The same procedures could be performed to analyze the inuence of Ahr1 onto the expression of
ALS3, HWP1 and IHD1, since data shows a binding of the hyperactive Ahr1 upstream of these
genes. As already mentioned, the described ChIP Seq results were obtained with a hyperactive
Ahr1. Working with a native Ahr1 might be more complicated due to lower expression rates
and lower protein levels, but could deliver more realistic results in terms of promoter binding
and transcription rates of the target genes. This would be especially important for answering
the question when Ahr1 binds to the ECE1 promoter after the initiation of hyphal growth. As
mentioned earlier, C. dubliniensis and C. tropicalis also synthesize Candidalysin. Since Ahr1
homologs can also be found in both species, the regulatory mechanism described here may be
conserved in other Candida species.
4.4. A hyperactive Ahr1 regulates other important transcriptional regulators
Aside the binding of the hyperactive Ahr1 to the promotors of ECE1 and ALS3, ChIP-Seq data
revealed, that the hyperactive Ahr1 bound upstream of several other genes, including those en-
coding for the transcription factors Bcr1, Brg1, Efg1, Tec1 and Ume6. As shown by RT-qPCR
analyses, this binding also signicantly increased the expression of these transcription factors
already under yeast growth conditions. This eect might mean that Ahr1 controls a wide ran-
ge of hyphae-associated processes. It is not clear if the binding upstream of these transcription
factors also has additional eects on the transcription of ALS3 and ECE1, since these transcrip-
tion factors also possess possible binding sites upstream of the ECE1 ORF. In deletion mutants
of these transcription factors ECE1 expression was reduced after serum-induction, indicating a
role of these regulators in ECE1 expression. However, integration of a hyperactive Ahr1 induced
high-level expression of ECE1 independent of Brg1, Ndt80, Tec1 and Ume6, which questions
their importance for the activation of the gene. Interestingly, analyses indicate that Ahr1 does
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not bind upstream of NRG1 or is involved in the negative regulation of NRG1. It is possible that
the aforementioned induction of BRG1 expression via hyperactive Ahr1 suppresses binding of
Nrg1 on target promotors already in yeast cells. This removal would allow the binding of Ahr1
to the promotors of ALS3, ECE1 and other target genes. Another option is that the hyperac-
tive Ahr1 itself suppresses Nrg1 promotor-binding in C. albicans yeast cells. Speaking for this
possible mechanism is the fact that the hyperactive Ahr1 induces high-level expression of ECE1
independently from BRG1.
The presented study focused on the regulation of ECE1 and other core lamentation response
genes. However, the ChIP-Seq data provide a lot of information about new targets of the Ahr1
transcription factor. As already mentioned, a hyperactive Ahr1 binds to the promotors and upre-
gulates the expression of genes, which are involved in hyphal initiation and maintenance, biolm
formation and adhesion. This opens up the possibility of a complex regulatory network with
Ahr1 in its center, which has yet to be examined.
Ahr1 also bound to its own upstream region, which coincides with already published data (Hern-
day et al., 2013). This suggests the existence of an autoregulatory feedback loop. In this case
expression of AHR1 was increased due to a hyperactive Ahr1. Since the hyperactive Ahr1 con-
struct was under the control of the ADH1 promotor, self regulation can not completely account
for increased messenger RNA levels.
Aside yeast-to-hyphae transition, C. albicans cells are also able to switch between the white and
the opaque cell type (Slutsky et al., 1987; Miller and Johnson, 2002). Ahr1, just like Efg1 and
Czf1, was shown to play an important role in the white cell type (Wang et al., 2011; Hernday
et al., 2013). Furthermore, data from this study indicates that Ahr1 plays a regulating role in hy-
phae, just like Efg1 in the cAMP-PKA pathway and Czf1 under embedded conditions (Sudbery,
2011; Brown Jr et al., 1999). Due to this, it would be interesting to research, whether the other
regulators of white-opaque-switching also play a role in ECE1 and ALS3 expression. Especially,
since it was shown, that Ahr1 binds upstream of WOR2 and EFG1 in white cells and CZF1,
WOR2,WOR1, EFG1 andWOR3 in opaque cells (Hernday et al., 2013). In white cells Efg1 and
Ahr1 bind upstream of AHR1. In opaque cells Wor1, Wor2 and Wor3 bind upstream of AHR1
and regulate its expression (Hernday et al., 2013). ChIP-analyses of the current study show that
the hyperactive Ahr1 bound upstream of WOR1, WOR2, WOR3, CZF1, and EFG1. Due to this,
future research could take a look at the role of Wor1, Wor2 and Wor3 during ECE1 expression.
It could for example be analyzed if a hyperactive Ahr1 is still able to induce ECE1 and ALS3
expression in the wor1∆, wor2∆, wor3∆ or czf1∆ mutants. Interestingly, Wang et al. (2011)
identied that Ahr1 activates white cell formation but only if Efg1, a key regulator for white
state maintenance is present. The data of this study show that for the regulation of several CFR
genes, the hyperactive Ahr1 works independent of Efg1(/Cph1). Furthermore, transcriptional
control of Wor1, the master regulator of the opaque cell type, is associated with Tup1, Ssn6 and
Tcc1 (Alkafeef et al., 2018). Here, Tup1 acts as major repressor of the opaque cell type, binding
to the promotor of WOR1 in white cells and repressing its expression (Alkafeef et al., 2018).
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4.5. A mutated SSN3 allele induces ECE1 and ALS3 expression independent of
Ahr1 and Tup1
Of course, it would also be interesting to identify putative regulators of Ahr1 which control
its function in response to environmental stimuli. Phosphorylation might be a suitable subject
for such further studies. For example, it was already shown that phosphorylation is important
for the activation or deactivation of transcription factors like Efg1 and Cst6 (Bockmühl et al.,
2001; Pohlers et al., 2017). In a previous study, it was shown that a point mutation in the SSN3
gene induces lamentation and upregulation of genes like ALS3 and ECE1 in the cph1∆/efg1∆
double mutant (Wartenberg et al., 2014), which is similar to the here presented results for
hyperactive Ahr1. Therefore, a closer look at the role of the kinase Ssn3 concerning the expression
of hypha-specic genes has been taken. Ssn3 (also known as Cdk8 in humans) is part of the cyclin-
dependent kinase (CDK) module of the mediator complex (Myers and Kornberg, 2000; Lewis
and Reinberg, 2003). It is a kinase involved in the phosphorylation of the RNA polymerase II
C-terminal domain and thus plays a role in regulating RNA polymerase II activity. The SNP
mutation in SSN3 described by Wartenberg et al. (2014) leads to an Arg352Gln substitution
in the substrate recognition loop of Ssn3. Subsequently, it was speculated by the authors that
due to reduced or impaired substrate recognition or phosphorylation activity of this kinase,
positive regulators of lamentous growth were stabilized or a derepression of the genes involved
in activation of lamentous growth was achieved (Wartenberg et al., 2014). An example for this
is that at high CO2 concentrations, Ssn3 is dephosphorylized by Ptc2 which in turn reduces the
phosphorylation of Ume6 by Ssn3 (Lu et al., 2019). Subsequently, the degradation of Ume6 is
prevented and hyphal development is maintained (Lu et al., 2019). In the current work and the
study of Wartenberg et al. (2014) one mutated SSN3 allele competed with the wild type allele(s)
on a position in the mediator complex. Nevertheless, already one mutated allele alone was enough
to promote the expression of hypha-specic genes (ECE1, ALS3, HWP1, IHD1 ). However, this
was achieved independently of Ahr1 and Tup1, indicating that an additional mechanism exists
which induces the high-level transcription of ECE1 and other core lamentation response genes.
In S. cerevisiae it was previously shown that Ssn3, as part of the mediator complex, is involved in
the repression of many genes in the presence of glucose, possibly as a target of Tup1 (Balciunas
and Ronne, 1995), since the catalytic activity of Ssn3 contributes to the repression of a subset
of Tup1-regulated genes (Kuchin et al., 1995; Green and Johnson, 2004). This might explain
other observations of this study, as ECE1 upregulation is not only caused by the aforementioned
mutates SSN3 allele, but also after the deletion of the SSN3 gene. A similar pattern was observed
for ALS3, HWP1 and IHD1. The upregulation of these genes correlated with hyphal formation in
the glucose-containing SDG medium at 37°C, which usually only triggers yeast growth. However,
Ssn3 is probably not only involved in the repression of genes. In S. cerevisiae Cdk8 (Ssn3 ortholog)
along with the mediator complex was shown to bind to sites of both activated and repressed genes
(Andrau et al., 2006). This demonstrates the complex nature of Ssn3 regulation. However, the
data provided here on Ssn3 are only preliminary. Future studies should focus on the detailed
regulation of target genes via Ssn3. The exact processes taking place at the respective promotors
still need to be elucidated.
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4.6. MCM1 overexpression induces the expression of ECE1 and ALS3 in partly
Ahr1-dependent manner
This study identied Ahr1 as an important regulator for CFR gene expression. As mentioned
before, Ahr1 has so far been connected to the regulation of adhesion genes (Askew et al., 2011),
white-opaque switching (Wang et al., 2011), amino acid utilization (Vylkova and Lorenz, 2017)
and biolm formation (Nobile and Johnson, 2015). Furthermore, Ahr1 was shown to recruit
Mcm1 to promotors of adhesion genes where the Ahr1-Mcm1-complex activated the expression
of ALS1, ALS4, HWP1, EFG1 and TEC1 (Askew et al., 2011). Just like Ahr1, Mcm1 possesses
possible binding sites upstream of the ECE1 ORF and was already proven to bind upstream of
ECE1, ALS3 and HWP1 in C. albicans hyphae (Lavoie et al., 2008; Tuch et al., 2008). Since
MCM1 is an essential gene, the eect of its deletion on ECE1 expression could not be analyzed.
Instead, aMCM1 overexpression was used to study the inuence of this regulatory gene on ECE1
expression. Indeed, it induced an upregulation of ECE1, ALS3, IHD1 and HWP1, similar to the
patterns which were observed with the hyperactive Ahr1. This eect was less pronounced in a
mutant lacking AHR1, showing that this mechanism is at least partially dependent on Ahr1. A
possible interplay between Ahr1 and Mcm1 on the promotors of ECE1 and ALS3 and IHD1 has
not yet been reported.
4.7. High-level expression of ECE1 and ALS3 relies on Tup1
Interestingly, the tup1∆ mutant displayed a similar phenotype as the ahr1∆ mutant. The ex-
pression of ECE1 was only intermediate in the tup1∆ mutant under hyphal growth conditions
compared to the wild type (Fig. 10). This correlated to a low secretion of Candidalysin, which
could be an explanation for the reduced cytotoxicity (Allert et al., 2018) and avirulence (Braun
et al., 2000; Straon et al., 2001) of this lamentous mutant. The current study indicates that,
just like in the ahr1∆ mutant, an intermediate expression of ECE1 and subsequent intermediate
levels of secreted Candidalysin are not enough to induce full virulence in the tup1∆ mutant.
Neither a hyperactive Ahr1 nor the overexpression of MCM1 could increase the transcription of
ECE1 or ALS3 up to wild-type level in the tup1∆ mutant.
4.8. Model for Ahr1-dependent transcription of ECE1 and ALS3 in C. albicans
hyphae
Based on all these observations, the following model for the transcriptional control of ECE1 and
ALS3 in C. albicans yeast and hyphal cells is being proposed (Fig. 31):
In yeast cells, the complex of Tup1 and Nrg1 represses the expression of ECE1 and ALS3
(Murad et al., 2001b; Braun et al., 2001; Murad et al., 2001a; Lu et al., 2011). This repression
is released after the initiation of hyphal growth (Martin et al., 2013; Lu et al., 2011; Kadosh
and Johnson, 2005; Murad et al., 2001a,b). The release is most likely mediated by degradation
of the Nrg1 protein (Lu et al., 2011). However, the fate of Tup1 was not studied so far. The
data presented in this study indicate that Tup1 remains at the promotors and contributes to
the Ahr1/Mcm1 mediated transcription of ECE1 and ALS3 in C. albicans' hyphae. However,
it is neither clear if this interaction is direct or indirect nor where Tup1 is actually localized. In
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contrast to Nrg1, Ahr1 and Mcm1, it does not contain a DNA binding domain. The proposed
Ahr1-dependent activation of ECE1 and ALS3 expression works alternatively from the already
mentioned MAPK and cAMP-PKA pathways where the activation of hypha-specic genes works
mainly via Efg1 and Cph1. In this model, Brg1 recruitment of Hda1 to promotors of hypha-
specic genes during hyphal elongation (Lu et al., 2012) is not needed since it was shown that
the action of the hyperactive Ahr1 is independent from Brg1.
Fig. 31: Model for the regulation of ECE1 and ALS3 in C. albicans' hyphae.
Under yeast growth conditions the expression of ECE1 and ALS3 is repressed by Tup1-
Nrg1. In parallel, Ssn3 prevents the expression of these genes via a so far unknown
mechanism or factor. Upon hyphal induction Ssn3 is deactivated and hypha-specic
genes are expressed. Independently, Ahr1 binds to the promotors of ECE1 and ALS3
and interacts with Tup1 and Mcm1 to activate the expression. Subsequent high-level
gene expression leads to a functional level of Candidalysin and Als3. This model may
also be valid for other virulence and hypha-specic genes.
The hypothesis that Tup1 plays a central role in the proposed model is supported by the fact
that Als3 localization on cell surfaces and Candidalysin amounts secreted from ahr1∆ and tup1∆
under hyphal growth conditions were reduced. The exact mechanism by which Ssn3 inactivates
and activates the transcription of ECE1 and ALS3 in yeast and hyphae, respectively, is so far
unknown. However, a possible link to Ume6 has already been described (Lu et al., 2019). This
study proves that neither Ahr1 nor Tup1 are necessary for the expression of these genes via the
mutated SSN3.
Speaking for a regulating role of Tup1 in C. albicans hyphae is that a Tup1-Tup1 interaction
(Tup1 forms tetramers with itself (Varanasi et al., 1996; Spargue et al., 2000)) was observed
after 1 h serum induction using a split-GFP system by Garbe (2016). With the same system,
a dissolution of the Tup1-Nrg1 interaction was observed after the initiation of hyphal growth
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(Garbe, 2016). For the proposed model, it would be necessary to examine possible physical
interactions between Tup1, Mcm1 and especially Ahr1 in future experiment. If it exists, such
an interaction could be proven by either a split-GFP approach or by co-immunoprecipitation.
Although both assays might prove an interaction between Tup1 and Ahr1, they are both limited
in the resolution of time. To show when exactly both regulators interact with each other, the
more dynamic Förster resonance energy transfer (FRET) assay could be applied. A more general
approach to prove an interaction would be a pull-down assay with Ahr1 and/ or Tup1.
The proposed model includes only Tup1, Ahr1 and Mcm1. However, there might be more factors
involved, including those which are known interaction partners of Tup1, especially Tcc1 and Ssn6
(Kaneko et al., 2006; Smith and Johnson, 2000). Like Tup1, Ssn6 contributes at least partially
to hyphal growth and associated gene expression (Hwang et al., 2003; Lee et al., 2015). Its
homolog in S. cerevisiae, Cyc8 was already shown to contribute to repression and activation of
gene expression, always together with its co-factor Tup1 (Smith and Johnson, 2000; Courey and
Jia, 2001; Papamichos-Chronakis et al., 2002; Mennella et al., 2003). In contrast, the role of Tcc1
is rather unknown. A pull-down assay with Ahr1 might show, if it interacts with one of these
co-factors. Interestingly, the ChIP-Seq data of this study showed that hyperactive Ahr1 could
bind to the promoter of TCC1 and induces its expression. This might be a hint to a possible
interaction. Another fascinating approach would be the usage of ChIP with selective isolation of
chromatin-associated proteins (ChIP-SICAP) followed by mass spectrometry (MS) (Raee et al.,
2016; van Wijlick et al., 2019). This method could be used to show an interaction between Tup1
and Ahr1/Mcm1 on hyphal chromatin, e.g. of the ECE1 promoter.
According to expression and ChIP-seq data from this study, the proposed model could also be
valid for HWP1 and IHD1. Furthermore, a binding of Mcm1 to the promotor of Hwp1 has already
been observed by others (Lavoie et al., 2008). Also further virulence and hypha-specic genes
could be regulated in an Ahr1-dependent manner. The hyperactive Ahr1 for example bound 807,
1144 and 833 bp upstream the hypha-specic genes SAP4, SAP5 and SAP6, respectively. Sap4-6
are secreted aspartyl proteinases and facilitate the liberation of nutrients from host cells and
play a role in the destruction and active penetration of tissue (Felk et al., 2002) and immune cell
evasion (Borg-von Zepelin et al., 1998). Furthermore, ChIP binding proles suggests that the
hyperactive Ahr1 regulates SOD5 expression. Sod5 is a superoxide dismutase and important for
the survival of C. albicans in blood (Fradin et al., 2005).
In summary, this study introduced Ahr1 as a novel key contributor of the regulation of hypha- and
virulence-associated genes. Its benecial role for the activation of ALS3 and ECE1 expression
depends on the presence of Tup1, indicating that the latter is not only important for repression,
but also activation of these genes, and might involve its interacting partner Mcm1. This adds
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Tab. 6: Possible transcription factor binding sites upstream of the ECE1 ORF.
Transcription factor binding motifs from the literature were identied in the ECE1














Ahr1_1 HGBBWAWWVHTDHH -2748 AGTTTATTCTTATC The perfect site would be
TCGNYWAWWSTTGCC
Hernday et al. (2013)
Ahr1_2 HGBBWAWWVHTDHH -2094 AGGCTAAAAATGCT
Ahr1_3 HGBBWAWWVHTDHH -352 CGCCTAAACTTGTA
Bcr1 TAMATRCAY -107 TAAATACAT
Perfect site:
TACATRCAYRWM
Nobile et al. (2012)
Brg1_1 MGGTAM -2735 CGGTAA
Brg1_2 MGGTAM -1252 AGGTAC Nobile et al. (2012)
Brg1_3 MGGTAM -810 AGGTAA
Cph1 TGAAACA -1521 TGAAACA
According to S. cerevisiae
Ste12 Harbison et al. (2004)
Efg1_1 RYGCATRD -1631 ATGCATG Nobile et al. (2012)
Efg1_2 CANNTG -2559 CATCTG
Argimón et al. (2007)
Efg1_3 CANNTG -2143 CAACTG
Efg1_4 CANNTG -1609 CAATTG
Efg1_5 CANNTG -1591 CAAGTG
Efg1_6 CANNTG -1103 CAAATG
Efg1_7 CANNTG -1053 CAAATG
Efg1_8 CANNTG -764 CAATTG
Efg1_9 CANNTG -498 CATTTG
Efg1_10 CANNTG -314 CAGGTG
Efg1_11 CANNTG -204 CAATTG
Efg1_12 TGCAT -2976 TGCAT
Hernday et al. (2013)
Efg1_13 TGCAT -2830 TGCAT
Efg1_14 TGCAT -2116 TGCAT
Efg1_15 TGCAT -1630 TGCAT
Fkh2_1 KTAAAYAAA -1243 TTAAACAAA According toS. cerevisiae
Fkh2_2 KTAAAYAAA -1080 GTAAACAAA Fkh2 Zhu et al. (2009)
Mcm1_1 WCGNNWAWWVTTNCY -2736 TCGGTAATTCTTCCC Tuch et al. (2008)
Mcm1_2 CCNNNNNNGG -1139 CCTAACTCGG According to S. cerevisiae















Ndt80_1 CRCAAA -2704 CACAAA
Ndt80_2 CRCAAA -1989 CGCAAA
Ndt80_3 CRCAAA -1810 CACAAA Chen et al. (2004);
Ndt80_4 CRCAAA -404 CACAAA Yang et al. (2012)
Ndt80_5 CRCAAA -379 CGCAAA
Ndt80_6 CRCAAA -329 CACAAA
Tec1 WRCATTCYH -2872 TACATTCTT Nobile et al. (2012)
Ume6_1 GCGG -2430 GCGG
Lu et al. (2013)Ume6_2 GCGG -2020 GCGG
Ume6_3 GCGG -971 GCGG
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Tab. 7: Secretion of Candidalysin of the wild type (SC514) and the cph1∆/efg1∆ and
the ahr1∆ mutants.
Strains were incubated for 18 h under yeast growth conditions (YNBS pH 4, 37°C)
and/or hyphal growth conditions (YNBS pH 7.2, 37°C). Candidalysin was extracted
from supernatant and measured by LC/MS-MS. Red font indicates the Ece1-III peptide.
PSM= peptide sprectum matches.
Yeast-inducing conditions PSM Hyphae-inducing conditions PSM





















cph1∆/ SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 37 SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 0
efg1∆ SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK 36
SIIGIIMGILGNIPQVIQIIMSIVKAFKGN 1
cph1∆/ SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 52 SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 352
efg1∆ SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK 40 SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK 286
+ SIIGIIMGILGNIPQVIQIIMSIVKAFKGN 9 SIIGIIMGILGNIPQVIQIIMSIVKA 26










Tab. 8: Identied binding motifs of hyperactive Ahr1 on intergenic regions of sought
out genes.
Sought out genes are displayed with their position in the C. albicans genome, the height
of the peak identied (the more reads were mapped to this region, the higher the cor-
responding peak) and the position of the motif identied including the motif score. The
higher the motif score the more the sequence concurs to the identied binding motif
(lowest score is 0, highest score is 6.58, cf. Fig. 20). Asterisks mark identied motifs that





















AHR1 orf19.7381 + chr3 791 6258 - 2,1 CACAACTAATAACGA
AHR1 orf19.7381 + chr3 791 6218 - 2,8 TGATATTTTAAGCGA
AHR1* orf19.7381 + chr3 791 5929 + 5,0 TGCAAGTATAACCGG
AHR1* orf19.7381 + chr3 791 5586 - 5,4 GGCAACAATTACCGG
AHR1 orf19.7381 + chr3 791 5584 + 3,9 GGTAATTGTTGCCGG
AHR1 orf19.7381 + chr3 791 4903 + 3,3 AGAAATAACACCCGA
AHR1 orf19.7381 + chr3 1050 2905 - 3,6 GTCAACTCAAACCGA
AHR1 orf19.7381 + chr3 1050 2453 - 2,6 GGAAATAATGAACGA
AHR1* orf19.7381 + chr3 1050 2397 + 3,5 AGCAACTATAACCTT
AHR1 orf19.7381 + chr3 1050 2177 - 2,6 TTAATCAATAACCGA
AHR1* orf19.7381 + chr3 1050 1669 - 4,9 AGCAAGTTTAACCGT
ALS1* orf19.5741 + chr6 2089 2570 + 2,3 GGTAAGATAATGCGA
ALS1 orf19.5741 + chr6 2089 1548 - 2,3 TTCAAGTAGAACAGA
ALS1* orf19.5741 + chr6 2089 1390 - 4,6 GGAAACTTCAAACGA
ALS1 orf19.5741 + chr6 2089 1293 - 3,8 AACAAGTTCTAGCGA
ALS1* orf19.5741 + chr6 2089 336 - 3,9 TGCAAGTTAAAACGA
ALS3* orf19.1816 - chrR 1478 340 + 4,5 TGCAAGTTAAACCGA
ALS3 orf19.1816 - chrR 1478 1118 + 3,4 AACAAGTGCTAGCGA
ALS3* orf19.1816 - chrR 1478 1209 + 3,5 GGAAACTTTGAACGA
ALS3* orf19.1816 - chrR 1478 1921 - 2,6 GGTTTTTTTAACCGA
ALS4 orf19.4555 - chr6 1140 1128 + 4,1 GGCAAGTTCTAACGT
ALS4* orf19.4555 - chr6 1140 1649 - 3,4 CACAAGTGTAAGCGA
BCR1* orf19.723 - chrR 676 2178 - 2,8 AGAAAGGAAAAGCGA
BCR1 orf19.723 - chrR 676 2232 + 2,1 GGAAACAATGGGAGA
BCR1 orf19.723 - chrR 676 2517 + 3,7 AGAAAGAAAAAGCGA
BRG1 orf19.4056 + chr1 544 5837 - 3,7 TGCAATTATAACAGA
BRG1* orf19.4056 + chr1 544 5765 + 5,1 TGCAAGAATTACCGA
BRG1 orf19.4056 + chr1 683 2470 - 2,3 CAAAAGATTAAACGA
BRG1 orf19.4056 + chr1 683 2161 - 3,3 AACAAGAAAAGCCGA
BRG1* orf19.4056 + chr1 683 2129 - 4,5 GGAATGAATAGCCGA
CDR1 orf19.6000 + chr3 696 1419 + 3,0 GGTGTGTTTAACCGA
CDR1* orf19.6000 + chr3 696 1337 + 4,7 ATCAACTATTGCCGA
CDR1 orf19.6000 + chr3 696 1282 - 2,5 AAGAAGTTGAGGCGA
CDR1* orf19.6000 + chr3 696 569 - 2,8 TTCAGTTTTAAGCGA
CZF1* orf19.3127 - chr4 681 4304 - 2,4 TGCAGTGGTAACCGA
DCK1 orf19.815 - chr2 327 124 - 2,3 GGAAATAAAAAGAGA
DCK1* orf19.815 - chr2 327 506 + 4,5 GGAAAGTATAGTCGA
EAP1 orf19.1401 + chr2 551 5622 + 2,3 TGAAATTTTAAACTA
EAP1 orf19.1401 + chr2 551 5225 + 3,4 GGTAAATACAAGCGA
EAP1 orf19.1401 + chr2 551 4773 - 2,7 AACTATTTTAGCCGA
EAP1 orf19.1401 + chr2 551 4701 - 3,2 AGCAGCTGCAAACGA























EAP1 orf19.1401 + chr2 1093 1326 - 4,5 TGCAACATTTCGCGA
EAP1* orf19.1401 + chr2 1093 1204 + 4,5 GGGAAGTTCAAGCGA
EAP1 orf19.1401 + chr2 1093 1008 + 4,1 TACAACTTTTGGCGA
ECE1* orf19.3374 - chr4 1676 996 - 4,2 TTCAAGTATTAGCGA
ECE1 orf19.3374 - chr4 1676 1103 + 2,8 GCCAACAACAGGCGT
ECE1 orf19.3374 - chr4 1676 1670 - 2,4 TTTATGTATTAGCGA
ECE1* orf19.3374 - chr4 1676 2015 - 2,9 CACAACTTTTAGCGG
ECE1 orf19.3374 - chr4 1676 2079 + 2,8 AGCATTTTTAGCCTA
ECE1* orf19.3374 - chr4 1676 2721 + 4,8 GGGAAGAATTACCGA
ECE1 orf19.3374 - chr4 1676 2773 + 2,3 GACAATTCTTGGAGA
EED1 orf19.7561 + chrR 673 2196 + 2,3 AAGAAGATTTGCCGG
EED1 orf19.7561 + chrR 673 2129 + 3,1 AGTAAGAATAAGAGA
EED1* orf19.7561 + chrR 673 1719 - 4,0 GTCAACTTCTGACGA
EED1 orf19.7561 + chrR 673 1674 + 2,7 GGCATCTTTACCCTC
EED1 orf19.7561 + chrR 673 1349 + 2,5 TGTATTTTTTAACGA
EED1 orf19.7561 + chrR 673 1243 - 3,5 GCCATTTTTAGCCGA
EED1 orf19.7561 + chrR 673 1078 - 3,3 TACAACTAATACCGA
EED1 orf19.7561 + chrR 673 495 - 4,0 GGAAATTAGAAACGA
EED1 orf19.7561 + chrR 673 110 - 2,2 TGAAAGTTAAAGCTA
EFG1 orf19.610 + chrR 648 7506 + 2,6 GGAAATATGAGCAGA
EFG1 orf19.610 + chrR 648 7227 - 3,7 GTCAATAATTGCCGG
EFG1* orf19.610 + chrR 648 7225 + 4,3 GGCAATTATTGACGT
EFG1 orf19.610 + chrR 648 6589 + 2,0 AGTAGTTTTAGCAGA
EFG1 orf19.610 + chrR 648 6501 - 2,6 AGCATGTAGAACCTA
EFG1 orf19.610 + chrR 2583 5867 + 2,2 GGCAAGTTAAAGATA
EFG1 orf19.610 + chrR 2583 4362 + 2,5 TACAACAACAACCGT
EFG1 orf19.610 + chrR 2583 3403 - 3,4 AGCAACTTTACTCGG
EFG1* orf19.610 + chrR 2583 3301 - 3,8 GTCAACTTTAAGAGA
EFG1 orf19.610 + chrR 2583 3199 + 2,8 GGAAAGTGAAAGAGA
EFG1 orf19.610 + chrR 2583 2946 - 2,8 AACAACAATAGGAGA
EFG1 orf19.610 + chrR 2583 2498 - 2,8 GGAATGAATTAGAGA
EFG1* orf19.610 + chrR 2583 2311 + 5,0 TGCAACTACAACCGA
FLO8* orf19.1093 - chr6 1435 2066 - 3,5 GGCAAGAAGTAGAGA
HGC1 orf19.6028 - chr1 886 10767 - 2,7 AACAATTAGTACCGG
HGC1* orf19.6028 - chr1 886 11187 - 3,3 GTAAACTATAGCCTA
HGC1 orf19.6028 - chr1 886 11590 - 2,3 AGTAATTCTAGCCTA
HGC1* orf19.6028 - chr1 886 11647 - 4,3 GGAAAGTGGTAGCGA
HGC1 orf19.6028 - chr1 886 11678 + 2,3 ATCAATTATTTGCGA
HGT2 orf19.3668 - chr1 1632 2254 - 2,9 GGGAACAATACACGT
HGT2 orf19.3668 - chr1 1632 2500 - 2,7 AAAAACTTTAATCGA
HGT2* orf19.3668 - chr1 1632 2952 + 3,5 AGCAACTTCTAGAGA
HGT2* orf19.3668 - chr1 1632 3442 + 4,9 TGCAACTATTCGCGA
HGT2 orf19.3668 - chr1 1632 3495 + 3,9 AGCAACAATACACGG
HGT2 orf19.3668 - chr1 1632 4076 + 2,3 AACAACATCAAACGC
HGT2 orf19.3668 - chr1 1632 4087 - 2,6 AGAAATAACAGGCGT
HGT2* orf19.3668 - chr1 701 5644 - 2,2 AGCATTTTTTGAAGA
HWP1 orf19.1321 + chr4 790 1875 - 2,1 ATAAACAATTACCTA
HWP1 orf19.1321 + chr4 790 1619 - 2,1 GGATTTTTTTGACGA
HWP1* orf19.1321 + chr4 790 1225 - 3,9 GGCAAGTTTATCCGC
HWP1 orf19.1321 + chr4 790 1106 - 3,2 GGCAACTCTTACCTT
HWP1 orf19.1321 + chr4 790 1104 + 3,2 GGTAAGAGTTGCCTA























HWP1 orf19.1321 + chr4 790 1030 + 2,3 AAAAGTTATTAGCGA
HWP1 orf19.1321 + chr4 790 6 - 3,2 CGAAACTAAAAGCGA
HYR1* orf19.4975 + chr1 538 6303 - 4,7 AGCAACAAGAACCGA
HYR1* orf19.4975 + chr1 1787 1938 + 4,8 AGCAATATTAGGCGA
HYR1 orf19.4975 + chr1 1787 1346 - 2,9 AGAAACAAAAACCGT
HYR1 orf19.4975 + chr1 1787 928 - 2,2 AGTAAGAATTGGCTG
HYR1 orf19.4975 + chr1 1787 792 + 3,0 TGAAATTCCAAGCGA
HYR1* orf19.4975 + chr1 1787 536 - 4,2 AACAATTTTAACCGA
HYR1* orf19.4975 + chr1 1787 186 - 4,7 GGAAAGTATTCACGA
IHD1* orf19.5760 - chr6 2931 -1534 + 4,1 GGAAAGTTGAACCGT
IHD1 orf19.5760 - chr6 2931 -1237 + 2,7 AGAATTTAAAACCGA
IHD1 orf19.5760 - chr6 2931 764 + 2,8 TACATTTTTTGCCGA
IHD1* orf19.5760 - chr6 2931 861 + 5,1 TGCAACAATTACCGA
IHD1 orf19.5760 - chr6 2931 979 - 3,7 AGAAAGAAAAAGCGA
IHD1 orf19.5760 - chr6 2931 1649 + 2,4 TGTAAGTAGAAACGT
LMO1 orf19.5147 + chr7 466 457 - 2,8 TTTATGTATAACCGA
LMO1* orf19.5147 + chr7 466 179 + 4,4 AGAAATTTTTAGCGA
MDR1 orf19.5604 - chr6 743 -124 - 2,2 GAAATATTTAGCCGA
MDR1 orf19.5604 - chr6 743 381 + 2,9 GGCAAGGAAAAACGG
MDR1* orf19.5604 - chr6 743 537 - 5,4 GGTAACTATTGGCGA
NDT80* orf19.2119 + chr2 854 1567 - 5,1 GGCAAGTTTAATCGA
RBT1* orf19.1327 - chr4 739 98 - 4,4 GGTAAGATTTACCGG
RIM101* orf19.7247 - chr1 490 664 - 5,1 AGCAAGTAGAGCCGA
RIM101 orf19.7247 - chr1 490 679 + 2,1 TGAAAGAAGTGACGT
RIM101 orf19.7247 - chr1 490 1079 + 2,3 ATAAAATGTAACCGA
RIM101 orf19.7247 - chr1 490 1157 - 3,6 CGCAACTATAGCAGA
SAP4 orf19.5716 - chr6 680 217 - 2,7 AGGAATTCTTGACGA
SAP4 orf19.5716 - chr6 680 651 + 2,0 GGGAAATAGAGGCGC
SAP4* orf19.5716 - chr6 680 807 - 3,8 AGCAATTTTAAGAGA
SAP5 orf19.5585 + chr6 543 1665 + 2,5 GGCAATAAATCTCGA
SAP5* orf19.5585 + chr6 543 1144 + 4,3 GGCAATTTTAAGAGA
SAP5* orf19.5585 + chr6 543 858 - 4,0 GTCAACTGGTACCGA
SAP5 orf19.5585 + chr6 543 837 - 2,5 GACAGGTATATGCGA
SAP5* orf19.5585 + chr6 543 470 + 3,6 GGAAAGAAAAAGCGG
SAP6 orf19.5542 - chr6 712 249 - 2,4 TGGAATTCTTGACGA
SAP6 orf19.5542 - chr6 712 448 - 2,6 AGAAAGAAAAAACGG
SAP6* orf19.5542 - chr6 712 833 - 3,5 GGTAATTTTAAGAGA
SAP6 orf19.5542 - chr6 712 1349 - 2,5 GGCAATAAATCTCGA
SFL1 orf19.454 - chrR 1065 5727 + 3,0 GGAAGGAATAGACGC
SFL1 orf19.454 - chrR 1065 6188 + 5,5 GGCAAGTTTTGGCGG
SFL1* orf19.454 - chrR 1065 6551 - 5,1 GGAAACTATTACCGG
SFL1 orf19.454 - chrR 1065 6823 - 2,6 GTTATGATTAAACGA
SFL1* orf19.454 - chrR 1065 7489 + 3,3 GGCAGTTGTTAGCGT
SFL1 orf19.454 - chrR 1065 8169 - 2,6 GATAATTTCTAACGA
SFL1 orf19.454 - chrR 597 9428 + 4,1 GGTAAGAAATACCGA
SFL1 orf19.454 - chrR 591 12499 + 2,3 GTAAACAGAAGACGA
SFL1 orf19.454 - chrR 591 12671 + 4,0 AACAACTATTACCGG
SFL1 orf19.454 - chrR 591 12772 - 2,1 AATAATAATAACCGT
SFL2* orf19.3969 + chr5 666 7759 + 3,2 ATCAAGAAAAAGCGA
SFL2* orf19.3969 + chr5 666 7235 + 3,6 GTAAACTATTCACGA
SFL2* orf19.3969 + chr5 1609 6157 + 3,7 AGTATCAATAGCCGA























SFL2 orf19.3969 + chr5 1609 5523 + 2,5 TCAAACAATAGACGA
SFL2* orf19.3969 + chr5 1609 5242 - 3,8 GGAAACTGAAAACGA
SFL2 orf19.3969 + chr5 1609 4840 - 2,7 ATAAACAATAAGCGT
SFL2 orf19.3969 + chr5 605 2833 + 2,1 AGTATTTTGAAACGA
SFL2* orf19.3969 + chr5 605 2733 + 4,0 AACAAGTAGAGCCGA
SFL2 orf19.3969 + chr5 605 2614 + 4,1 AGCAAATATTGGCGA
SFL2 orf19.3969 + chr5 605 2604 + 2,2 GGCGAAAGTTGGCGA
SFL2 orf19.3969 + chr5 605 2594 + 2,2 GGCGAAAGTTGGCGA
SOD5 orf19.2060 - chr2 711 520 - 2,0 GGCAATTGATTACGA
SOD5 orf19.2060 - chr2 711 522 + 2,3 GTAATCAATTGCCGT
SOD5 orf19.2060 - chr2 711 755 + 3,8 TTCAATTTTTACCGA
SOD5* orf19.2060 - chr2 711 888 + 4,9 GGCATCTTTTCCCGA
SOD5 orf19.2060 - chr2 711 996 + 2,0 AAAAATAACAAACGA
SOD5 orf19.2060 - chr2 711 1042 - 2,7 GTTAAGTTCTCACGA
SOD5* orf19.2060 - chr2 711 1512 + 4,9 GGAAAGTTGAAGCGA
SOD5 orf19.2060 - chr2 711 1791 - 2,0 ACTAACTATTGCAGA
SOD5* orf19.2060 - chr2 711 1839 - 4,2 AGCAATTATTCACGA
SOD5 orf19.2060 - chr2 711 1993 - 2,4 ATCAGCTAATAGCGA
STP2* orf19.4961 + chr1 639 1496 - 2,2 GGTAAAAATAAGAGA
STP2* orf19.4961 + chr1 639 915 + 2,9 TGCAAGACTTGCAGA
STP2 orf19.4961 + chr1 639 419 + 2,6 GGAAAGAGGAGGAGA
TCC1* orf19.6734 + chr3 705 8002 + 3,2 AGTAACTTCAAACGG
TCC1 orf19.6734 + chr3 705 7945 + 3,8 AGCAATAAAAAGCGA
TCC1* orf19.6734 + chr3 705 7019 + 2,1 ATCATCATCAACCGG
TCC1 orf19.6734 + chr3 705 6624 - 4,6 GACAAGTTTTGACGA
TCC1* orf19.6734 + chr3 705 6528 - 2,1 GGATAGTTTTAAAGA
TCC1 orf19.6734 + chr3 854 1486 - 2,6 AGCAATATTAATCGT
TCC1* orf19.6734 + chr3 854 1475 + 3,2 TGCTAGTATTAGCGG
TEC1 orf19.5908 - chr3 628 1109 + 2,1 GTATACTAATACCGA
TEC1* orf19.5908 - chr3 628 1477 - 2,4 GGTAGTTATTAGAGA
TEC1 orf19.5908 - chr3 1754 3461 + 2,1 GTCATTTGTTAACGG
TEC1* orf19.5908 - chr3 1754 3943 - 3,5 GACAAGATTACGCGC
TEC1* orf19.5908 - chr3 1754 4383 - 3,0 GTTAATTCTTAGCGA
TEC1 orf19.5908 - chr3 1754 4874 + 2,8 GTCAAGAAAAAGCGT
TEC1* orf19.5908 - chr3 1754 5005 - 4,8 GGCAAGTATAAGCTA
TEC1 orf19.5908 - chr3 1754 6065 - 2,9 TGCAAGACTAGGAGA
TEC1 orf19.5908 - chr3 1754 6187 - 2,8 TGGAACAAATACCGA
TEC1 orf19.5908 - chr3 1754 6247 - 2,2 GGATGTTATAAACGA
TEC1* orf19.5908 - chr3 1754 6281 - 3,3 GTAAAGAATTACCGT
TEC1 orf19.5908 - chr3 1754 6553 + 4,0 GGAAAGTATACCAGA
UME6 orf19.1822 - chr1 1108 6881 + 2,1 AACAAGTACAAAAGA
UME6 orf19.1822 - chr1 1108 7204 + 3,6 GGAAATTATTAGAGA
UME6* orf19.1822 - chr1 1108 7283 - 3,7 GTAAAGTAAAACCGA
UME6 orf19.1822 - chr1 1108 7577 - 2,7 AGAAATTATAGAAGA
UME6* orf19.1822 - chr1 1108 7675 + 2,9 TTCAGGAATTACCGA
UME6* orf19.1822 - chr1 1108 8177 + 2,9 AGCATGAATAGGAGA
UME6 orf19.1822 - chr1 1108 8219 + 2,7 ATCAATTTTAGCCTA
UME6 orf19.1822 - chr1 1108 8259 - 2,1 AAAAACATTTGCAGA
UME6 orf19.1822 - chr1 1108 8285 - 2,1 TGCATGTGTTCACGT
UME6 orf19.1822 - chr1 539 12233 - 3,1 AGTAAGAATAAGAGA
UME6 orf19.1822 - chr1 539 12864 - 2,4 TGTATGTATAACAGA























UME6 orf19.1822 - chr1 1082 15221 + 2,8 GGCAGGAATAACGGA
UME6 orf19.1822 - chr1 1082 15515 - 4,1 GGCAAGAATAAAAGA
UME6* orf19.1822 - chr1 1082 15928 + 4,2 AACAACTTTAAACGA
UME6 orf19.1822 - chr1 1082 16066 + 3,3 ATCAAATTTAGCCGA
WOR1* orf19.4884 + chr1 647 6170 - 4,2 TGCAACTTGAAACGA
WOR1* orf19.4884 + chr1 647 5648 - 5,0 AGCAAGTATAGCCGT
WOR1 orf19.4884 + chr1 647 5047 + 2,9 AGTAAGTGTTGGAGA
WOR2* orf19.5992 + chr3 1407 9450 + 4,8 GTCAACATTAAGCGA
WOR2 orf19.5992 + chr3 1878 4252 + 3,5 AGCAAGTTGTATCGA
WOR2 orf19.5992 + chr3 1878 4116 - 2,1 ATAAAATTTAAACGA
WOR2 orf19.5992 + chr3 1878 3548 - 2,8 GGTAACTTTGCACGA
WOR2 orf19.5992 + chr3 1878 3504 - 2,5 TGCTACTTGTAACGA
WOR2 orf19.5992 + chr3 1878 3170 - 3,8 GGCAAGAATGAACGA
WOR2 orf19.5992 + chr3 1878 2813 - 3,3 AGTAAGTTGAACCGT
WOR2* orf19.5992 + chr3 1878 2755 - 4,3 GTCAATTGTTGCCGA
WOR2 orf19.5992 + chr3 1878 2610 + 2,2 AGCAAGTTTAATAGC
WOR2 orf19.5992 + chr3 1878 2444 + 3,3 GGGAAATATTCCCGA
WOR2* orf19.5992 + chr3 1878 1834 + 5,0 GGCATCAATTACCGA
WOR2 orf19.5992 + chr3 1878 1115 + 2,4 GGGAAGATGAGACGT
Fig. 32: Deletion of SSN3 induces the expression of ECE1 in SDG medium at 37°C.
Wild type and the ssn3∆ mutant with ECE1 -promotor driven GFP-reporter systems
(pECE1 -GFP) were grown for 4 h in indicated yeast and hyphal inducing media at 37°C
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